C07K

Peptides & Proteins (Biologics)

EPO Patent Bulletin

← All categories
Filter: All Correction Grant Limitation Publication Search Report

740 items

Limitation

Wheat Stripe Rust Resistance Genes And Methods Of Use

EP3370509C0 · Mar 18, 2026
Grant

Wheat Stripe Rust Resistance Genes And Methods Of Use

EP3370509B1 · Mar 18, 2026
Grant

Method For Treating Multiple Sclerosis

EP3359572B1 · Mar 18, 2026
Grant

Mammalian Cell Culture

EP2837680B1 · Mar 18, 2026
Grant

Pc5 As A Factor Ix Propeptide Processing Enzyme

EP2650305B1 · Mar 18, 2026
Grant

Methods For Isolating A Target Analyte From A Heterogeneous Sample

EP2699693B1 · Mar 18, 2026
Publication

Polynucleotide Influenza Vaccine Encoding Hemagglutinin And Neuramidase

EP2026030759A1 · Mar 18, 2026
Publication

Use Of A Rxr Agonist In Treating Cancer

EP2026030729A1 · Mar 18, 2026
Publication

Synthesis Of 1 Butanol From Carbon Dioxide By Engineered Hydrogen Bacteria

EP2026030726A1 · Mar 18, 2026
Publication

Systems And Methods For Protein Design

EP2026030717A1 · Mar 18, 2026
Publication

Adhesion Molecules For Targeted Infiltration Of Therapeutic Cells

EP2026030704A1 · Mar 18, 2026
Publication

Zein Extraction And Paper Coating Process For Sustainable Packaging

EP2026030693A1 · Mar 18, 2026
Publication

Materials And Methods For Treating Senescence Related Disorders

EP2026030685A1 · Mar 18, 2026
Grant

Human Herpesvirus Trimeric Glycoprotein B, Protein Complexes Comprising Trimeric Gb And Their Use As Vaccines

EP3079718B1 · Mar 18, 2026
Publication

Methods For Selectively Targeting Neuronal Pathways

EP2026030664A1 · Mar 18, 2026
Publication

Vista Binding Antibodies And Methods Of Use Thereof

EP2026030622A1 · Mar 18, 2026
Publication

Systems And Methods For Concurrent Measurements Of Plurality Of Protein Reactions

EP2026030606A1 · Mar 18, 2026
Publication

Human Anti Sars Cov 2 Spike (S) Antibodies

EP2026030604A1 · Mar 18, 2026
Publication

Squid Derived Conductive Protein And Manufacturing Method Thereof

EP2026029650A1 · Mar 18, 2026
Publication

Molecules For Controlling Allergic Diseases

EP2026030647A1 · Mar 18, 2026
Publication

Pcv2 E, Pcv3 C, And Pcv4 Vaccines

EP2026030635A2 · Mar 18, 2026
Publication

Sustained Transgene Expression Of Imid Responsive Peptide Suicide Protein Fusion Polypeptides And Uses Thereof

EP2026030634A2 · Mar 18, 2026
Publication

Compositions And Methods For Treating Cancers

EP2026030629A1 · Mar 18, 2026
Publication

Biomarker Composition For Diagnosing Or Inducing Senescence, Comprising Hmgb1

EP2026029371A1 · Mar 18, 2026
Publication

Long Acting Cyclic Peptides For Inhibiting Tnf Receptor 1 Activity

EP2026030184A1 · Mar 18, 2026
Publication

Recombinant Vaccinia Vectors And Methods Of Use Thereof

EP2026030145A1 · Mar 18, 2026
Publication

Fusion Protein Compositions And Methods Relating To Hemostatic Therapy

EP2026030137A1 · Mar 18, 2026
Publication

Anti Integrin ?8?1 Antibody

EP2026029176A1 · Mar 18, 2026
Publication

Systems And Methods For Extraction Of Halogenated Compounds And/Or Phycoerythrins

EP2026030273A1 · Mar 18, 2026
Publication

Human Papillomavirus (Hpv) Vaccines

EP2026030253A1 · Mar 18, 2026
Publication

Compositions For Alzheimer's Disease Vaccines

EP2026030249A1 · Mar 18, 2026
Publication

Methods And Compositions For Treatment Of Cytokine Release Syndrome

EP2026030235A1 · Mar 18, 2026
Publication

Novel Antibacterial Polypeptide And Variant Thereof

EP2026029563A1 · Mar 18, 2026
Publication

Methods Of Assessing Urine Samples For Antibodies Of Interest

EP2026030221A1 · Mar 18, 2026
Publication

Human Antibody Against Coronavirus Mutant Strain, Or Antigen Binding Fragment Thereof

EP2026029035A1 · Mar 18, 2026
Publication

Curating A Biofilm Using Bioengineered Bacteria

EP2026030202A1 · Mar 18, 2026
Publication

Vaccine Antigens And Use Thereof

EP2026030201A2 · Mar 18, 2026
Publication

Synthetic Protein, Complex, Composition, Polynucleotide, Expression Vector, Transformant, Osteogenesis Promoter, Cartilage Proliferation Promoter, Angiogenesis Promoter, And Pharmaceutical Composition

EP2026028952A1 · Mar 18, 2026
Publication

Anti Ptk7 Chimeric Antibody And Anti Ptk7 Humanized Antibody, And Uses Thereof

EP2026029362A1 · Mar 18, 2026
Publication

Treating Multiple Myeloma With Anti Cd3/Bcma Bispecific Antibody In Combination With An Anti Cd38 Antibody

EP2026030537A1 · Mar 18, 2026
Publication

Activated Hepatocyte Growth Factor

EP2026030528A1 · Mar 18, 2026
Publication

Methods For Improved Gene Insertion And Expression In Cell Lines

EP2026030518A1 · Mar 18, 2026
Publication

Escrt Independent Evlp Inducing Domains

EP2026030505A1 · Mar 18, 2026
Publication

Assays, Kits And Methods For Detection Of Influenza

EP2026030496A1 · Mar 18, 2026
Publication

Treatment Of Conditions Related To Cxcr2 Loss Of Function

EP2026030589A1 · Mar 18, 2026
Publication

Processes For The Purification Of Viral Particles And Formulations Thereof

EP2026030432A1 · Mar 18, 2026
Publication

Methods Of Use Of Agents That Bind To Nkg2 A And Pd L1

EP2026030408A1 · Mar 18, 2026
Publication

Anti Human Ror1 Antibody Drug Conjugate And Uses Thereof

EP2026030396A1 · Mar 18, 2026
Publication

Bvdv Ibrv Bivalent Mrna Vaccine And Use Thereof

EP2026026951A1 · Mar 18, 2026
Publication

Anti Cd74 Antibody, Antibody Drug Conjugate, And Preparation Method Therefor And Use Thereof

EP2026026939A1 · Mar 18, 2026
Publication

Antigen Binding Protein Targeting Cd38 And Use Thereof

EP2026026938A1 · Mar 18, 2026
Publication

Use Of Dipeptide Derivative

EP2026026911A1 · Mar 18, 2026
Publication

Formulation Of Tri Specific Antibody Binding To Human Gprc5 D/Bcma/Cd3 And Use Thereof

EP2026026893A1 · Mar 18, 2026
Publication

Modified Live Attenuated Flu Virus Vaccines And Uses Thereof

EP2026030318A1 · Mar 18, 2026
Publication

Gamma Delta Tcr Antibody And Uses Thereof

EP2026026865A1 · Mar 18, 2026
Publication

Vector Comprising Multiple Targeting Molecules, And Method For Improving Transduction Efficiency Of Vector

EP2026026586A1 · Mar 18, 2026
Publication

B7 H3 Specific Antibody And Anti Tumor Use Thereof

EP2026026847A1 · Mar 18, 2026
Publication

Anti Il 5 Antibody Formulation And Preparation Method Therefor

EP2026026827A1 · Mar 18, 2026
Publication

Peptide Inhibitor Of Interleukin 23 Receptor And Use Thereof

EP2026026816A1 · Mar 18, 2026
Publication

Peptide Inhibitor Of Interleukin 23 Receptor And Use Thereof

EP2026026815A1 · Mar 18, 2026
Publication

A Bioactive Peptide Composition

EP2026028044A1 · Mar 18, 2026
Publication

Hybrid Retinal Neuroprosthesis And Methods Of Using The Same

EP2026028201A1 · Mar 18, 2026
Publication

Novel Squaraine Dye Peptide Complex

EP2026028655A1 · Mar 18, 2026
Publication

Method For Producing Protein

EP2026028728A1 · Mar 18, 2026
Publication

Antibody Binding To Steap1 Or Antigen Binding Fragment Thereof, And Use Thereof

EP2026026986A1 · Mar 18, 2026
Publication

Antibody Binding To Steap1 Or Antigen Binding Moiety And Use Thereof

EP2026026985A1 · Mar 18, 2026
Publication

Bispecific Antibody, Antibody Drug Conjugate, Preparation Method Therefor And Use Thereof

EP2026026981A1 · Mar 18, 2026
Publication

Novel Engineered Protein Delivery Vehicles For Enhanced Delivery

EP2026026977A1 · Mar 18, 2026
Publication

Anti Claudin18.2 Nanobody, Chimeric Antigen Receptor And Uses Thereof

EP2026026965A1 · Mar 18, 2026
Publication

Humanized Nanobody Targeting Bcma And Use Thereof

EP2026026960A1 · Mar 18, 2026
Publication

Anti Biofilm And Anti Microbial Composition

EP2026028584A1 · Mar 18, 2026
Publication

Protein L Single Domain Fusion Antibody

EP2026028549A1 · Mar 18, 2026
Publication

Protein L Binding Polypeptide And Use Thereof

EP2026028548A1 · Mar 18, 2026
Publication

Guide Rnas For Editingserpina1

EP2026028149A1 · Mar 18, 2026
Publication

Methods And Compositions For Treatment Of Disease

EP2026030334A1 · Mar 18, 2026
Publication

Methods And Compositions For Treatment Of Disease

EP2026030328A1 · Mar 18, 2026
Publication

Dsg2 Antibody And Uses Thereof

EP2026026858A1 · Mar 18, 2026
Publication

Recombinant Collagen And Use Thereof

EP2026026676A1 · Mar 18, 2026
Publication

Construction, Preparation And Use Of Universal Dual Target Bcma/Cd19 Mbil15 Car Dnt Cell Having Enhanced Function

EP2026026761A1 · Mar 18, 2026
Publication

Bap4 H Mutant And Use Thereof

EP2026026211A1 · Mar 18, 2026
Publication

Bap4 H Mutant, Preparation Method Therefor, And Use Thereof

EP2026026210A1 · Mar 18, 2026
Publication

Multispecific Antigen Binding Protein And Use Thereof

EP2026026529A1 · Mar 18, 2026
Publication

Anti Fibrotic Peptide, Vaccine, Preparation Method For Peptide Vaccine, And Use Thereof

EP2026026264A1 · Mar 18, 2026
Publication

Proteo Lipid Vehicles Formulated With Fusion Associated Small Transmembrane (Fast) Proteins For Administration Of Leptin

EP2026025194A1 · Mar 18, 2026
Publication

Anti Sirp Alpha Antibody Formulations And Uses Thereof

EP2026027944A1 · Mar 18, 2026
Publication

Herv K (Hml 2) Env Analog Fusion Proteins For Antigen Specific Immunotherapy And Methods Of Use

EP2026030596A1 · Mar 18, 2026
Publication

West Nile Virus Neutralizing Monoclonal Antibodies

EP2026030473A1 · Mar 18, 2026
Publication

Synthesis Of Glp 1 R/Gipr Agonists

EP2026030654A1 · Mar 18, 2026
Publication

Herv K (Hml 2) Env Analog Fusion Proteins For Antigen Specific Immunotherapy And Methods Of Use

EP2026030597A1 · Mar 18, 2026
Publication

Degradation Targeting Agents And Uses Thereof

EP2026030445A1 · Mar 18, 2026
Publication

Prostate Specific Antigen Peptides And Uses Thereof

EP2026030428A2 · Mar 18, 2026
Publication

Use Of Semaphorin 4 D Inhibitory Molecules To Treat Cognitive Impairment

EP2026030311A1 · Mar 18, 2026
Publication

Herv K (Hml 2) Env Analog Fusion Proteins For Antigen Specific Immunotherapy And Methods Of Use

EP2026030592A1 · Mar 18, 2026
Publication

Methods For Treating High Risk Smoldering Multiple Myeloma

EP2026028163A1 · Mar 18, 2026
Publication

Bifunctional Degraders For The Treatment Of Graves' Disease

EP2026028159A1 · Mar 18, 2026
Publication

Herv K (Hml 2) Env Analog Fusion Proteins For Antigen Specific Immunotherapy And Methods Of Use

EP2026030590A1 · Mar 18, 2026
Publication

Optimized Dna Cassettes For Gene Therapy

EP2026030354A2 · Mar 18, 2026
Publication

Rna Molecules

EP2026030275A1 · Mar 18, 2026
Publication

Cell Penetrating Peptides And Compounds Comprising Cell Penetrating Peptides For Drug Delivery

EP2026027613A1 · Mar 18, 2026
Publication

Improved Immunoglobulin Single Variable Domains That Inhibit Urease And Use Thereof

EP2026027659A1 · Mar 18, 2026
Publication

Hepatitis Delta Virus Polypeptides And Detection

EP2026027625A1 · Mar 18, 2026
Publication

Sequencing Reagents Using Guanidinylating Agents

EP2026030423A1 · Mar 18, 2026
Publication

Chimeric Antigen Receptor

EP2026027876A1 · Mar 18, 2026
Publication

Amyloid Inhibitory Peptides

EP2026027796A1 · Mar 18, 2026
Publication

Formulations Of Anti Gremlin 1 Antibodies

EP2026027660A1 · Mar 18, 2026
Publication

Co Stimulatory T Cell Receptor To Treat Patient With Tumor Or Immune Related Disease

EP2026029677A1 · Mar 18, 2026
Publication

Inhibitory Peptides For Cathepsin D And Lrp 1 Interaction

EP2026027599A1 · Mar 18, 2026
Publication

Signal Peptides For Increased Protein Secretion

EP2026027251A1 · Mar 18, 2026
Publication

Pea Lines With Improved Taste Profile Of A Pea Ingredient

EP2026027749A1 · Mar 18, 2026
Publication

Pea Lines With Improved Taste Profile

EP2026027746A1 · Mar 18, 2026
Publication

Extraction And Purification Of (Apo)ferritin From Blood Plasma And Plasma Fractions

EP2026027779A1 · Mar 18, 2026
Publication

Alpha V Beta 6 Integrin Binding Cyclopeptides With Non Natural Amino Acids, And Conjugates Thereof

EP2026027771A1 · Mar 18, 2026
Publication

Microbial Production Of Recombinant Mink Hair Keratins For Textile Applications

EP2026027489A1 · Mar 18, 2026
Publication

Cxcr4 Ligand Suitable For Radiopharmaceutical Applications And Method For Preparation Thereof

EP2026027415A1 · Mar 18, 2026
Publication

Site Specific Antibody Conjugation And Antibody Drug Conjugate As Specific Example Thereof

EP4711386A2 · ABTIS Co., Ltd. · Mar 18, 2026
Publication

Methods Of Treating Psoriasis Using Il 17 Antagonists

EP4670788A2 · Novartis AG · Mar 18, 2026
Publication

Anti Axl Antibodies, Antibody Fragments And Their Immunoconjugates And Uses Thereof

EP4656204A2 · BioAtla, Inc. · Mar 18, 2026
Publication

Car For Use In The Treatment Of Hvg Disease

EP4671278A2 · Medizinische Hochschule Hannover · Mar 18, 2026
Publication

Car T Cells Against Cd79 B For The Treatment Of Non Hodgkin Lymphoma

EP4667494A2 · Fundación Instituto de Investigación Sanitaria Fundación Jiménez Díaz · Mar 18, 2026
Search Report

Specific Modification Of Antibody With Igg Binding Peptide

EP4699621A3 · Kagoshima University · Mar 18, 2026
Publication

Specific Modification Of Antibody With Igg Binding Peptide

EP4699621A2 · Kagoshima University · Mar 18, 2026
Publication

Anti C Met Antibody Drug Conjugates

EP4656248A2 · AbbVie Manufacturing Management Unlimited Company · Mar 18, 2026
Publication

Antibodies Binding To Citrullinated Histone 2 A And/Or 4

EP4659807A2 · Citryll B.V. · Mar 18, 2026
Publication

T Cell Phenotypes Associated With Response To Adoptive Cell Therapy

EP4667936A2 · The United States of America, as represented by the Secretary, Department of Health and Human Services · Mar 18, 2026
Search Report

Recombinant Rsv Antigens

EP4670734A3 · GlaxoSmithKline Biologicals S.A. · Mar 18, 2026
Publication

Recombinant Rsv Antigens

EP4670734A2 · GlaxoSmithKline Biologicals S.A. · Mar 18, 2026
Publication

Qbp1 For Use In The Treatment And/Or Prevention Of Diabetes

EP2026027088A1 · Mar 18, 2026
Publication

Method For Purifying Antibody Having Low Isoelectric Point

EP4671270A2 · CHUGAI SEIYAKU KABUSHIKI KAISHA · Mar 18, 2026
Publication

Feline Antibody Variants

EP4711383A2 · Zoetis Services LLC · Mar 18, 2026
Publication

Anti C1 S Antibodies And Methods Of Use Thereof

EP4652926A2 · Bioverativ USA Inc. · Mar 18, 2026
Publication

Multimeric Il 15 Based Molecules

EP4613776A2 · Altor BioScience, LLC · Mar 18, 2026
Publication

Generating Mammalian T Cell Activation Inducible Synthetic Promoters (Syn+Pro) To Improve T Cell Therapy

EP4613864A2 · Seattle Children's Hospital d/b/a Seattle Children's Research Institute · Mar 18, 2026
Search Report

Irak Degraders And Uses Thereof

EP4613773A3 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Irak Degraders And Uses Thereof

EP4613773A2 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Bispecific Antibodies Against Cd3 And Cd20

EP4678661A2 · Genmab A/S · Mar 18, 2026
Publication

Preparation Of Factor Xa Derivatives

EP4588932A2 · ALEXION PHARMACEUTICALS, INC. · Mar 18, 2026
Publication

Anti Cd79 B Antibody Drug Conjugates

EP4670742A1 · AbbVie Inc. · Mar 18, 2026
Search Report

Therapeutic Molecules

EP4556491A3 · Crescendo Biologics Limited · Mar 18, 2026
Publication

Therapeutic Molecules

EP4556491A2 · Crescendo Biologics Limited · Mar 18, 2026
Publication

Compositions And Methods For Treating Cancer

EP4559477A2 · Adagene AG · Mar 18, 2026
Publication

Construction And Application Of Fusion Protein Vaccine Platform

EP4566671A2 · Institute of Biophysics Chinese Academy of Sciences · Mar 18, 2026
Publication

Enhanced Delivery Of Drugs And Other Compounds To The Brain And Other Tissues

EP4548924A2 · Duke University · Mar 18, 2026
Publication

Methods For Array Synthesis

EP4556467A2 · Vibrant Holdings, LLC · Mar 18, 2026
Publication

Composition For Regulating Cancer Cell Division Or Differentiation Comprising Setdb1 Or A Setdb1 Inhibitor

EP4559526A2 · Korea Advanced Institute of Science and Technology · Mar 18, 2026
Publication

Methods Of Treating Bladder Cancer

EP2026029772A1 · Mar 18, 2026
Publication

Nucleic Acid Polypeptide Compositions And Methods Of Inducing Exon Skipping

EP4556489A2 · Avidity Biosciences, Inc. · Mar 18, 2026
Publication

Expression Vector For Rspo1 Protein And Use Thereof

EP2026025571A1 · Mar 18, 2026
Publication

Immunogenic Mycoplasma Pneumoniae Polypeptide Epitope And Recombinant Protein Containing Same, And Mycoplasma Pneumonia Vaccine

EP2026025554A1 · Mar 18, 2026
Publication

Anti Digoxigenin Antibody Or Antigen Binding Fragment Thereof, And Use Thereof

EP2026025284A1 · Mar 18, 2026
Publication

Synthetic Helper Genes For Enhancing Viral Production

EP2025035137A2 · Synvivia, Inc. · Mar 18, 2026
Publication

Enhanced Formulation Of Polymyxin B/ Trimethoprim And Rifampin And Methods For Ophthalmic Uses

EP2025030169A2 · Arcum Vision Inc. · Mar 18, 2026
Publication

Anti Cthrc1 T Cell Engagers And Methods Of Using The Same

EP2025015320A2 · Phenomic AI · Mar 18, 2026
Publication

Compositions And Methods For Purifying Viral Vectors

EP4709740A2 · North Carolina State University · Mar 18, 2026
Publication

Ige Binding Proteins And Uses Thereof

EP2025015286A2 · Inhibrx Biosciences, Inc. · Mar 18, 2026
Publication

Therapy For Alpha 1 Antitrypsin Deficiency

EP2025014986A2 · Precigen, Inc. · Mar 18, 2026
Publication

Coronavirus Spike Glycoprotein Receptor Binding Domains And Uses Thereof

EP4709741A1 · Icosavax, Inc. · Mar 18, 2026
Publication

Compact Proteins

EP4709851A2 · Vertex Pharmaceuticals Incorporated · Mar 18, 2026
Publication

A Combination Comprising Lag 3 Targeting Moiety And Interleukin 10

EP4709761A2 · Elixiron Immunotherapeutics (Hong Kong) Limited · Mar 18, 2026
Publication

Oncoselective Therapy

EP4709864A1 · Kernal Biologics, Inc. · Mar 18, 2026
Publication

Compositions And Methods For Engineering T Cells For Improved Tumor Infiltration And Uses Thereof

EP4709843A2 · THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE · Mar 18, 2026
Publication

B. Burgdorferi Peptidoglycan Antibodies And Uses Thereof

EP4709421A2 · Virginia Tech Intellectual Properties, Inc. · Mar 18, 2026
Publication

Peptoid Compositions Targeting Ras Proteins And Methods Of Treatment Of Cancer Using The Same

EP4709403A2 · University of Houston System · Mar 18, 2026
Publication

Fluorescein Labeled Nerve Targeting Peptide Formulations And Related Methods

EP4709405A2 · Alume Biosciences, Inc. · Mar 18, 2026
Publication

Immunohistochemistry (Ihc) Protocols And Methods For Diagnosing And Treating Cancer Claudin 18.2

EP4710112A2 · Agilent Technologies, Inc. · Mar 18, 2026
Publication

High Concentration Formulations For Monoclonal Antibodies

EP4709760A2 · Icahn School of Medicine at Mount Sinai · Mar 18, 2026
Publication

Human Monoclonal Antibodies For Treating Subjects Suffering From Pulmonary Fibrosis

EP4709764A2 · The Johns Hopkins University · Mar 18, 2026
Publication

Chimeric Antigen Receptors And Methods Of Use Thereof

EP4709485A1 · Legend Biotech Ireland Limited · Mar 18, 2026
Publication

Anti Kras/Hla Antibodies And Uses Thereof

EP4709744A1 · Biocytogen Pharmaceuticals (Beijing) Co., Ltd. · Mar 18, 2026
Publication

Use Of Radiopharmaceuticals For Treatment Of Cancer

EP2024229575A1 · Fusion Pharmaceuticals Inc. · Mar 18, 2026
Publication

Lipid Complex

EP4711463A1 · Eisai R&D Management Co., Ltd. · Mar 18, 2026
Publication

Multi Projectile Antibody Drug Conjugate, And Preparation Method Therefor And Use Thereof

EP4710946A1 · Medilink Therapeutics (Suzhou) Co., Ltd. · Mar 18, 2026
Publication

Exhaled Breath Condensate Contains Extracellular Vesicles (Evs) With Mirna Cargos Of Lung Tissue Origin That Can Be Selectively Purified And Analyzed

EP4709399A2 · Hackensack Meridian Health, Inc. · Mar 18, 2026
Publication

Agents That Bind To Cd16 A And Uses Thereof

EP4709763A1 · Avantgen, Inc. · Mar 18, 2026
Publication

Revision Of Genetic Material Using Direct Replacement Editing

EP4709870A1 · Transit Therapeutics, Inc. · Mar 18, 2026
Publication

Alkaline Phosphatase Antibodies And Uses Thereof

EP4709762A2 · Chosen Diagnostics Inc. · Mar 18, 2026
Publication

Immunotherapeutic Proteins

EP4709759A1 · Macfarlane Burnet Institute for Medical Research and Public Health Limited · Mar 18, 2026
Publication

Immunotherapeutic Proteins

EP4709765A1 · Macfarlane Burnet Institute for Medical Research and Public Health Limited · Mar 18, 2026
Publication

Combination Of Antibody Drug Conjugate And Other Medicine

EP4699622A1 · Daiichi Sankyo Company, Limited · Mar 18, 2026
Publication

Bispecific Chimeric Antigen Receptors Targeting Bcma And Cd19

EP4695301A2 · AbelZeta Inc. · Mar 18, 2026
Publication

Ligand Cytotoxicity Drug Conjugates And Pharmaceutical Uses Thereof

EP4687998A1 · Hansoh Bio LLC · Mar 18, 2026
Publication

Agents Useful For The Prevention Or Treatment Of Allergic & Inflammatory Disorders

EP4669337A1 · ATOPIA THERAPEUTICS SA · Mar 18, 2026
Publication

Beverage Clarification Using Recombinant Ova Or Ovd

EP2024197288A1 · Mar 18, 2026
Publication

Transcytotic Intercellular Gelation Enables Cell Spheroids

EP2024197259A1 · Mar 18, 2026
Publication

Vaccine Adjuvants

EP4709394A2 · Seqirus Inc. · Mar 18, 2026
Publication

Ig Like Fusion Proteins For Treating Immune Thrombocytopenia

EP4709407A1 · Canopy Immuno-Therapeutics Ltd. · Mar 18, 2026
Publication

Ig Like Fusion Proteins For Treating Graves Disease

EP4709747A1 · Canopy Immuno-Therapeutics Ltd. · Mar 18, 2026
Publication

Ig Like Fusion Proteins For Treating Membranous Nephropathy

EP4709746A1 · Canopy Immuno-Therapeutics Ltd. · Mar 18, 2026
Publication

Combination Vaccine

EP4709420A1 · Seqirus Inc. · Mar 18, 2026
Publication

Cas Protein, Corresponding Gene Editing System Thereof And Use Thereof

EP4711451A1 · Yoltech Therapeutics Co., Ltd · Mar 18, 2026
Publication

Engineered Liver Specific Core Promoters And Their Applications

EP4709859A1 · SICHUAN REAL&BEST BIOTECH CO., LTD. · Mar 18, 2026
Publication

Engineered Liver Specific Enhancers And Their Applications

EP4709858A1 · SICHUAN REAL&BEST BIOTECH CO., LTD. · Mar 18, 2026
Publication

Methods Of Treating Alzheimer's Disease

EP2024197258A1 · Mar 18, 2026
Publication

Methods And Compositions For Diagnosis Of Ectopic Pregnancy, Intrauterine Pregnancy, And Spontaneous Abortion

EP2024196873A1 · Mar 18, 2026
Publication

Methods And Compositions For Diagnosis Of Ectopic Pregnancy

EP2024196872A1 · Mar 18, 2026
Publication

Two Cell Not Gate Comprising Synthetic Immuno Suppressive Cells

EP2024196802A1 · Mar 18, 2026
Publication

Combined Targeted And Untargeted Proteomics

EP2024196780A2 · Mar 18, 2026
Publication

Developing An Anti Human Cd45 Imaging Probe For Noninvasive Detection Of Human Immune Cells

EP2024196776A2 · Mar 18, 2026
Publication

Novel Polypeptide Bax/Npm Inhibitors

EP2024196750A1 · Mar 18, 2026
Publication

Membrane Vesicles Comprising Multiple Influenza Antigens For Vaccines

EP2024196719A2 · Mar 18, 2026
Publication

Chimeric Antibody Molecules Based On Tetrameric Teleost Immunoglobulin M

EP2024196707A2 · Mar 18, 2026
Publication

Pd 1 Agonist Antibodies And Methods Of Treating Inflammatory Or Autoimmune Skin Diseases With A Pd 1 Agonist Antibody

EP2024196694A2 · Mar 18, 2026
Publication

Dna Vaccine Targeting Overexpressed Antigens In Colorectal Cancer

EP2024196664A1 · Mar 18, 2026
Publication

Variant Threonine/Homoserine Export Protein And Method For Producing L Amino Acids Using Same

EP2024196192A1 · Mar 18, 2026
Publication

Variant Threonine/Homoserine Export Protein And Method For Producing L Amino Acids Using Same

EP2024196191A1 · Mar 18, 2026
Publication

Tumor Antigen Cancer Vaccine Platform And Use Thereof

EP2024196177A1 · Mar 18, 2026
Publication

Cell Culture Substrate For Osteocyte Differentiation And Preparation Method Therefor

EP2024196171A1 · Mar 18, 2026
Publication

Novel Anti Human R Spondin 3 Antibody And Use Thereof

EP2024196163A1 · Mar 18, 2026
Publication

Novel Anti Human R Spondin 2 Antibodies And Use Thereof

EP2024196162A1 · Mar 18, 2026
Publication

H3 Subtype Influenza Virus With Cross Immunogenicity And Vaccine Comprising Same

EP2024196133A1 · Mar 18, 2026
Publication

Protein Therapeutics For Treatment Of Senescent Cells

EP4709912A1 · BioAtla, Inc. · Mar 18, 2026
Publication

Targeted Viral Transduction Of B Cells

EP4709867A1 · The Regents of the University of California · Mar 18, 2026
Publication

Anti Bacterial Peptides

EP4709739A1 · Agency for Science, Technology and Research · Mar 18, 2026
Publication

Therapeutic Agents And Compositions And Related Methods

EP4709749A1 · Koru Biotech Solutions Limited · Mar 18, 2026
Publication

Targeting Prac1 In Steroid Hormone Driven Cancer

EP2024197199A2 · Mar 18, 2026
Publication

Peptide Substrates And Inhibitors Of Cathepsin B

EP2024197174A1 · Mar 18, 2026
Publication

Senotherapy For Treating And Preventing Neurodegenerative Disease

EP2024197007A1 · Mar 18, 2026
Publication

Ultracompact Precision Editing Systems And Uses Thereof

EP2024196911A1 · Mar 18, 2026
Publication

Rabbit Monoclonal Antibodies Targeting Acute Myeloid Leukemia Antigens

EP2024196877A1 · Mar 18, 2026
Publication

Broadening T Cell Help By Antigen Cross Linking On A Multivalent Scaffold

EP2024197156A1 · Mar 18, 2026
Publication

Coronavirus Spike Protein Based Vaccines

EP2024197134A1 · Mar 18, 2026
Publication

Broadly Neutralizing Human Monoclonal Antibodies That Target The Sars Cov 2 Receptor Binding Domain (Rbd)

EP2024196463A2 · Mar 18, 2026
Publication

A Glycation Resistant Insulin Polypeptide And A Method Of Preparing The Same Thereof

EP2024194897A1 · Mar 18, 2026
Publication

Sacituzumab Drug Conjugates And Preparation Thereof

EP4680644A1 · Zydus Lifesciences Limited · Mar 18, 2026
Publication

Cell Immunotherapy Composition And Method

EP2024193714A1 · Mar 18, 2026
Publication

Bivalent Il 17 Therapeutic Vaccine, Preparation Method Therefor, And Use Thereof

EP2024193713A1 · Mar 18, 2026
Publication

Conjugate Of Anti Ror1 Antibody And Pbd Compound, And Preparation Method Therefor And Use Thereof

EP2024193691A1 · Mar 18, 2026
Publication

Ror1 Targeting Antibody, Antibody Drug Conjugate Comprising Same, Preparation Method Therefor, And Use Thereof

EP2024193605A1 · Mar 18, 2026
Publication

Vaccines And Methods Of Use Thereof

EP2024192465A1 · Mar 18, 2026
Publication

Cd98 Hc Bispecific Antibodies

EP2024192433A1 · Mar 18, 2026
Publication

Interferon Alpha 2 Variants

EP2024192373A1 · Mar 18, 2026
Publication

Alternative Strategies For Methanobactin Production

EP2024192335A1 · Mar 18, 2026
Publication

Runx1 Modulators

EP2024192283A1 · Mar 18, 2026
Publication

Inverted Cytokine Receptors And Methods Of Use Thereof

EP2024193687A1 · Mar 18, 2026
Publication

Anti Tpbg/Met Antibodies And Uses Thereof

EP2024193682A1 · Mar 18, 2026
Publication

Anti Tnfr2/Anti Pd 1 Or Ctla 4 Bispecific Antibody And Use Thereof

EP2024193669A1 · Mar 18, 2026
Publication

Anti Ctla 4/Anti Tigit Bispecific Antibody And Use Thereof

EP2024193668A1 · Mar 18, 2026
Publication

Fusion Protein Of Anti Pd 1/Anti Tigit Bispecific Antibody And Il 2 And Use Thereof

EP2024193665A1 · Mar 18, 2026
Publication

Peptide Derived From Crotalphine, Composition Comprising The Said Peptide, Its Use And Method To Treat Acute Or Chronic Pain

EP2026025169A1 · Mar 18, 2026
Publication

Ctgf Targeting Antibody Or Antigen Binding Fragment Thereof, And Use Thereof

EP2024188179A1 · Jiangxi Kangleite Xinsen Pharmaceutical Raw Materials Co., Ltd · Mar 18, 2026
Publication

New Uses Of Omalizumab

EP4683947A1 · Novartis AG · Mar 18, 2026
Publication

Nanoantibody B12 Targeting Ceacam5 And Use Of Nanoantibody B12

EP2024149232A1 · The Third Affiliated Hospital of Southern Medical University (Academy of Orthopedics Guangdong Province) · Mar 18, 2026
Publication

Triple Mrna Vaccine For Preventing Feline Rhinotracheitis, Feline Calicivirus Diseases, And Feline Panleukopenia, And Preparation Method Therefor

EP4649958A1 · Zhejiang University · Mar 18, 2026
Publication

Methods And Compositions For Reducing Antibody Viscosity

EP4709758A1 · Genentech, Inc. · Mar 18, 2026
Publication

Extracellular Vesicles For The Delivery Of Payloads To Eukaryotic Cells

EP4709745A1 · Alaya.Bio Inc. · Mar 18, 2026
Publication

Interferon Receptor Antagonists And Uses Thereof

EP4709757A1 · Regeneron Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Anti Phosphocholine Antibodies And Methods Of Use Thereof

EP2024194685A2 · Mar 18, 2026
Publication

Method For Detecting Interactions

EP4710107A1 · Oxford University Innovation Limited · Mar 18, 2026
Publication

Targeted Interferon Alpha Fusion Proteins And Methods Of Use

EP4709752A1 · F. Hoffmann-La Roche AG · Mar 18, 2026
Publication

Bispecific Anti Pseudomonas Antibodies With Modified Fc Regions And Methods Of Use Thereof

EP4709750A1 · Astrazeneca AB · Mar 18, 2026
Publication

New Ternatin Type Cyclopeptides For Use In Therapy

EP4709482A1 · Centre National de la Recherche Scientifique · Mar 18, 2026
Publication

Intravaginal Formulations Of Gardnerella Endolysins

EP4709404A1 · BioNTech SE · Mar 18, 2026
Publication

Ph Sensitive Antibodies

EP4709748A1 · Danmarks Tekniske Universitet · Mar 18, 2026
Publication

Glycosylation Of Immunoglobulin Single Variable Domains

EP4709751A1 · Sanofi · Mar 18, 2026
Publication

Immunoglobulin Preparations For Treatment Of Systemic Sclerosis

EP4709487A1 · CSL Behring AG · Mar 18, 2026
Publication

Cd20 Pd1 Binding Molecules And Methods Of Use Thereof

EP4709756A1 · Regeneron Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Compositions And Methods For Recombinant Aav Production

EP4709866A2 · REGENXBIO Inc. · Mar 18, 2026
Publication

Improved Crispr/Cas Guide Rna (Grna)

EP4709854A1 · Evox Therapeutics Limited · Mar 18, 2026
Publication

Modulators Of Protein Secretion

EP4709874A1 · Sanofi · Mar 18, 2026
Publication

Means And Methods For The Expansion Of Nk Cells

EP4709754A1 · Christian-Albrechts-Universität zu Kiel · Mar 18, 2026
Publication

Slc4 A4/Nbce1 Inhibitors

EP4709753A1 · VIB VZW · Mar 18, 2026
Publication

Method For Diagnosing Neurodegenerative Diseases

EP4710113A1 · Noselab GmbH · Mar 18, 2026
Publication

Modified Helicases

EP4709742A1 · Oxford Nanopore Technologies PLC · Mar 18, 2026
Publication

Antibodies Capable Of Binding To Ox40, Variants Thereof And Uses Thereof

EP4709411A1 · Genmab A/S · Mar 18, 2026
Publication

Pharmaceutical Compositions Comprising A Bispecific Bcma/Cd3 Antibody At High Concentration

EP4709755A1 · Janssen Biotech, Inc. · Mar 18, 2026
Publication

A Nasal Fluid Sample Comprising A Beta, Ptau And/Or Tta

EP4710114A1 · Noselab GmbH · Mar 18, 2026
Publication

Mhc Class I Molecules

EP4709743A1 · Immudex ApS · Mar 18, 2026
Publication

Methods And Compositions For Treating Cancer

EP4709484A1 · GENENTECH, INC. · Mar 18, 2026
Publication

Furin Sensors And Applications Thereof

EP4709738A1 · FlareOn Biotech GmbH · Mar 18, 2026
Publication

Split Inteins For Affinity Capture

EP4709737A1 · Cytiva BioProcess R&D AB · Mar 18, 2026
Publication

Identification Of Neoantigen Reactive T Cell Receptors

EP2024197072A2 · Mar 18, 2026
Publication

Gene Therapy

EP2024194223A2 · Mar 18, 2026
Publication

Antibodies For Detecting Extracellular Vesicles

EP2024194326A1 · Mar 18, 2026
Publication

Polynucleotides Encoding Relaxin For The Treatment Of Heart Failure

EP2024197033A1 · Mar 18, 2026
Publication

Treatment Of Non Small Cell Lung Cancer

EP4694872A1 · Astrazeneca AB · Mar 18, 2026
Publication

Engineered T Cells And Uses Thereof

EP2024194649A1 · Mar 18, 2026
Publication

Dosage Regimens For The Administration Of A Bispecific Antibody In Combination With Chemotherapy

EP2024194482A1 · Mar 18, 2026
Publication

Expression Of Animal Myofibrillar Proteins In Plants

EP2024194831A1 · Mar 18, 2026
Publication

Engineered T Regulatory Cell

EP2024194642A1 · Mar 18, 2026
Publication

Compounds For Inducing Tissue Regeneration And Uses Thereof

EP4567043A2 · Histide AG · Mar 18, 2026
Publication

Compounds For Inducing Tissue Regeneration And Uses Thereof

EP4541810A2 · Histide AG · Mar 18, 2026
Publication

Virus Filtration Methods

EP4559926A2 · F. Hoffmann-La Roche AG · Mar 18, 2026
Publication

Nucleic Acids And Uses Thereof

EP4661903A1 · Pfizer Inc. · Mar 18, 2026
Publication

Human Immunodeficiency Virus (Hiv) Neutralizing Antibodies

EP4549461A2 · Theraclone Sciences, Inc. · Mar 18, 2026
Publication

Non Human Animals Comprising A Humanized Asgr1 Locus

EP4484562A2 · Regeneron Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Methods Of Enhancing Immunogenicity Of Poorly Immunogenic Antigen Specific Vaccines Using Oral Yeast Beta Glucans

EP4509185A2 · Memorial Sloan Kettering Cancer Center · Mar 18, 2026
Publication

Mice Expressing A Limited Immunoglobulin Light Chain Repertoire

EP4545567A2 · Regeneron Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Compositions And Methods That Promote Hypoxia Or The Hypoxia Response For Treatment And Prevention Of Mitochondrial Dysfunction And Oxidative Stress Disorders

EP4512819A2 · The General Hospital Corporation · Mar 18, 2026
Publication

Peptidic Opioid Receptor Antagonists And Uses Thereof

EP4711387A1 · Université de Genève · Mar 18, 2026
Publication

Improved Serum Albumin Binders

EP4471058A2 · Ablynx NV · Mar 18, 2026
Publication

Improved Serum Albumin Binders

EP4442709A2 · Ablynx NV · Mar 18, 2026
Publication

Improved Serum Albumin Binders

EP4442708A2 · Ablynx NV · Mar 18, 2026
Publication

Determining Antigen Recognition Through Barcoding Of Mhc Multimers

EP4484450A2 · Herlev Hospital · Mar 18, 2026
Publication

Pharmaceutical Composition Comprising Ccn5 As Active Ingredient For Preventing Or Treating Retinal Disease

EP4365299A2 · Olives Biotherapeutics Inc. · Mar 18, 2026
Publication

Dosing Regimen For Anti Bcma Agents

EP4424709A2 · Amgen Research (Munich) GmbH · Mar 18, 2026
Publication

Human Neuregulin 1 (Nrg 1) Recombinant Fusion Protein Compositions And Methods Of Use Thereof

EP4361177A2 · Salubris Biotherapeutics, Inc. · Mar 18, 2026
Publication

Nangibotide For Use In Treating Sepsis Shock

EP4474013A2 · Inotrem · Mar 18, 2026
Publication

Variants Of Cpf1 (Cas12 A) With Altered Pam Specificity

EP4481049A2 · The General Hospital Corporation · Mar 18, 2026
Publication

Method For Producing Cd3 Positive Cell

EP4455166A2 · Kyoto University · Mar 18, 2026
Publication

Markers Of Acute Myeloid Leukemia Stem Cells

EP4470556A2 · The Board of Trustees of the Leland Stanford Junior University · Mar 18, 2026
Publication

Enhancing The Therapeutic Activity Of An Immune Checkpoint Inhibitor

EP4342544A2 · MaineHealth · Mar 18, 2026
Publication

Methods And Compositions For Increasing Arylsulfatase A Activity In The Cns

EP4338797A2 · Armagen, Inc. · Mar 18, 2026
Publication

Methods For Treatment Using Adoptive Cell Therapy

EP4427810A2 · Juno Therapeutics, Inc. · Mar 18, 2026
Publication

Rac2 G12 V Mutant For Use In Ablating Hematopoiesis And In The Treatment Of Hematopoietic Malignancies

EP4414002A2 · Institut National de la Santé et de la Recherche Médicale · Mar 18, 2026
Publication

Long Acting Gip Peptide Analogues

EP4361173A2 · University of Copenhagen · Mar 18, 2026
Publication

Trajectory Determination Method Based On Bacterial Flagella Stain Image

EP2024193105A1 · Mar 18, 2026
Publication

Blood Coagulation Factor Ix Mutant And Use Thereof

EP2024193018A1 · Mar 18, 2026
Publication

Polypeptide Antagonist Targeting Human Respiratory Syncytial Virus Fusion Glycoprotein

EP2024192698A1 · Mar 18, 2026
Publication

Nac25 Gene And Use Thereof In Regulating Tomato Flowering Traits

EP2024192768A1 · Mar 18, 2026
Publication

Anti Cd27 Monoclonal Antibody And Use Thereof

EP2024187743A1 · Mar 18, 2026
Publication

Monoclonal Antibody 2 C1 For Identifying Eb Virus Gp42 Protein, And Use Of Monoclonal Antibody 2 C1

EP2024187675A1 · Mar 18, 2026
Publication

Cathepsin L Inhibitors

EP4619388A1 · Biofront Therapeutics (Beijing) Co., Ltd. · Mar 18, 2026
Publication

Adeno Associated Virus Mutant And Use Thereof

EP2024138809A1 · Packgene Biotech Co., Ltd. · Mar 18, 2026
Publication

Antimicrobial Peptide Rich In Tryptophan And Having Self Assembly Properties, And Use Thereof

EP2024131811A1 · Nanoqure Biotech (Shenzhen) Co., Ltd. · Mar 18, 2026
Publication

Broad Spectrum Neutralizing Antibodies For Novel Coronavirus Omicron Mutant Strain And Use

EP2024131774A1 · Beijing Changping Laboratory · Mar 18, 2026
Publication

Recombinant Human 2 Ig B7 H3 Protein Coding Gene, Recombinant Vector, Host Cell, Pharmaceutical Composition And Use Thereof

EP2024148521A1 · Shanghai Renyousheng Gene Technology Co., Ltd. · Mar 18, 2026
Publication

Integrin Beta 6 (Itgb6) Targeting Trispecific Protein For Treatment Of Cancer

EP4633740A2 · Harpoon Therapeutics, Inc. · Mar 18, 2026
Publication

Diagnosis Of Bartonella Using Recombinant Proteins

EP4634665A1 · ID-Fish Technology, Inc. · Mar 18, 2026
Publication

Cyclic Peptides As Pet Imaging Agents Of Granzyme B

EP4634205A2 · Merck Sharp & Dohme LLC · Mar 18, 2026
Publication

Cosmetic Composition For Skin Improvement

EP4635974A1 · LG Household & Health Care Ltd. · Mar 18, 2026
Publication

Anti Cd155 Antibody And Use Thereof

EP4631976A1 · Hefei TG Immunopharma Co., Ltd. · Mar 18, 2026
Publication

Anti Muc 16 Antibodies And Methods Of Use Thereof

EP4634231A1 · University of Saskatchewan · Mar 18, 2026
Publication

Antibodies Or Fragments Thereof For Sars Cov 2 And Variants Thereof

EP4630447A2 · Abwiz Bio, Inc. · Mar 18, 2026
Publication

Nucleic Acid Based Cancer Vaccine And Methods Thereof

EP4630562A1 · Advanced RNA Vaccine (ARV) Technologies, Inc. · Mar 18, 2026
Publication

Silk Leather And Related Materials, And Methods Of Making And Using The Same

EP4634410A1 · Trustees of Tufts College · Mar 18, 2026
Publication

Methods Of Treating Sarcoidosis With A Tnf A Antibody And Associated Compositions And Methods

EP4630056A2 · Xentria, Inc. · Mar 18, 2026
Publication

Methods For Treating Dll3 Expressing Cancer

EP4630458A2 · Amgen Inc. · Mar 18, 2026
Publication

Methods And Systems For Glycoprotein Assays

EP4630442A1 · Seer, Inc. · Mar 18, 2026
Publication

Detection Of Cytocapsular Tubes In Tissue For Cancer Metastasis Analysis

EP4590716A1 · CELLMIG BIOLABS INC. · Mar 18, 2026
Publication

Intelligent Design And Engineering Of Proteins

EP4630966A2 · The Regents of the University of California · Mar 18, 2026
Publication

Bispecific Fusion Protein Targeting Tnf ? And Il 17 A, And Use Thereof

EP4635988A1 · Jiangsu Kanion Pharmaceutical Co., Ltd. · Mar 18, 2026
Publication

Fusion Comprising Anti Tau Antibody And Peptide And Use Thereof

EP4631975A1 · Adel Inc. · Mar 18, 2026
Publication

Novel Peptide

EP4631966A1 · Hysensbio Co., Ltd · Mar 18, 2026
Publication

Bispecific Autoantigen Immune Effector Cell Engaging Antibodies And Uses Thereof

EP4630459A1 · The Johns Hopkins University · Mar 18, 2026
Publication

Methods And Compositions For Treating Ocular Lesions

EP4630029A1 · ONL Therapeutics, Inc. · Mar 18, 2026
Publication

Novel Hiv 1 Variants And Their Methods Of Use In An Animal Challenge Model

EP4630439A1 · The Regents Of The University Of Colorado · Mar 18, 2026
Publication

Methods And Compositions For Improving Visual Function In Ocular Diseases And Disorders

EP4630031A2 · ONL Therapeutics, Inc. · Mar 18, 2026
Publication

Antibody Design Method Through Machine Learning

EP4625420A1 · RevolKa Ltd. · Mar 18, 2026
Publication

Bifunctional Compounds And Pharmaceutical Uses Thereof

EP4630422A1 · Risen (Suzhou) Pharma Tech Co., Ltd. · Mar 18, 2026
Publication

Methods For Diagnosing And Treating Ovarian Cancer

EP4630044A1 · Carina Biotech Limited · Mar 18, 2026
Publication

Method For Separating Glycopeptides

EP4631954A1 · KH Neochem Co., Ltd. · Mar 18, 2026
Publication

Method For Isolating Glycopeptide

EP4631953A1 · KH Neochem Co., Ltd. · Mar 18, 2026
Publication

Hepatitis B Vaccine

EP2024108955A1 · Pingshan Translational Medicine Center, Shenzhen Bay Laboratory · Mar 18, 2026
Publication

Pharmaceutical Composition Comprising Anti Rankl Ngf Bispecific Antibodies

EP4620483A1 · Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Mar 18, 2026
Publication

Protein Protein Interaction Modulators And Methods For Design Thereof

EP4630438A1 · Ramot at Tel Aviv University Ltd. · Mar 18, 2026
Publication

Improved System For Producing Rna Packaged Aav Particles

EP4630062A1 · Huidagene Therapeutics (Singapore) Pte. Ltd. · Mar 18, 2026
Publication

Anti Ilt4 Antibody As Well As Preparation Method Therefor And Use Thereof

EP4628508A1 · Biodlink Biopharm Co., Ltd. · Mar 18, 2026
Publication

Il 17 A Antibody Formulation And Use Thereof

EP4631522A1 · Shanghai Huaota Biopharmaceutical Co., Ltd. · Mar 18, 2026
Publication

Antibody Specifically Binding To Rsv

EP4631974A1 · Nanjing Vazyme Biotech Co., Ltd. · Mar 18, 2026
Publication

Antibodies Specifically Binding To Rsv

EP4588936A1 · Changchun Bcht Biotechnology Co. · Mar 18, 2026
Publication

Modified Cell And Use Thereof

EP4632074A1 · Suzhou Grit Biotechnology Co., Ltd. · Mar 18, 2026
Publication

Formulation And Use Of A Fusion Protein

EP4630460A1 · Zhu, Daocheng · Mar 18, 2026
Publication

Compounds Targeting Sstr2, Preparation Method Therefor, And Use Thereof

EP4613758A1 · Yantai Lannacheng Biotechnology Co., Ltd. · Mar 18, 2026
Publication

Adeno Associated Virus Mutant And Use Thereof

EP2024119598A1 · Packgene Biotech Co., Ltd. · Mar 18, 2026
Publication

Binary Self Amplifying Nucleic Acid Platform And Uses Thereof

EP4612305A1 · THE UNIVERSITY OF BRITISH COLUMBIA · Mar 18, 2026
Publication

Porphyria Disease Models

EP4604721A2 · Agios Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Use Of Tdgf1 Gene In Preparation Of Drugs For Treating Aging Related Diseases Or Reversing Cell Aging

EP2024078124A1 · Allife Regenerative Medicine Tech. Beijing Co. Ltd · Mar 18, 2026
Publication

A Method Of Rescuing Exhausted Immune Cells

EP4590710A1 · Currus Biologics Pty Ltd · Mar 18, 2026
Publication

Insulin Treatment To Improve T Cell Engineering

EP4634212A1 · GENENTECH, INC. · Mar 18, 2026
Publication

Anti Rhd Antibodies For Treating Inflammatory Dermal Condition

EP2024050455A2 · Heitmeyer, Jamie Nicole · Mar 18, 2026
Publication

Antibody Binding To Thyroid Stimulating Hormone Receptor And Use Thereof

EP4582451A1 · Shanghai Scizeng Medical Technology Co., Ltd. · Mar 18, 2026
Publication

Combination Treatment With Orelabrutinib And Tafasitamab

EP2024037594A1 · Beijing InnoCare Pharma Tech Co., Ltd. · Mar 18, 2026
Publication

Composite Immune Biomarkers And Uses Thereof

EP4611811A1 · Foundation Medicine, Inc. · Mar 18, 2026
Publication

Pbase Protein, Fusion Protein, Nucleic Acid, Gene Integration System And Use

EP4636082A2 · GeCell Therapeutics, LLC. · Mar 18, 2026
Publication

Single Domain Antibody Targeting Human Ror1

EP4613774A1 · Nanjing Probio Biotech Co., Ltd. · Mar 18, 2026
Publication

High Stability Recombinant Collagen, And Construction Method Therefor And Use Thereof

EP4567044A1 · Jiangsu Trautec Medical Technology Co., Ltd. · Mar 18, 2026
Publication

Cd47 Blocking Agent And Anti Cd20 / Anti Cd3 Bispecific Antibody Combination Therapy

EP4630034A2 · Pfizer Inc. · Mar 18, 2026
Publication

Anti Cd28 Humanized Single Domain Antibody

EP2024022516A1 · Sichuan Swiftbio Biotechnology Co., Ltd · Mar 18, 2026
Publication

Optimizing Polypeptide Sialic Acid Content

EP4634397A1 · Genentech Inc. · Mar 18, 2026
Publication

Real Time Automated Monitoring And Control Of Ultrafiltration/Diafiltration (Uf/Df) Conditioning And Dilution Processes

EP4634646A1 · Genentech Inc. · Mar 18, 2026
Publication

Recombinant Collagen And Use Thereof In Cartilage Repair Matrix

EP4600268A1 · Shanxi Jinbo Biopharmaceutical Co., Ltd. · Mar 18, 2026
Publication

Respiratory Syncytial Virus Recombinant Fusion Protein Having Pre Fusion Conformation, And Preparation Method Therefor And Use Thereof

EP4578878A1 · Beijing Benewill Technology Development Co., Ltd. · Mar 18, 2026
Publication

Anti 4 1 Bb Nanobody, Preparation Therefor, And Use Thereof

EP4592317A1 · ABlink Biotech Co., Ltd. · Mar 18, 2026
Publication

Engineered Switches For Immune Cell Activity And Methods Of Use Thereof

EP4630446A1 · Dynamic Cell Therapies, Inc. · Mar 18, 2026
Publication

Treatment Of Prion Diseases

EP4634209A1 · Regeneron Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Methods Of Administering Belumosudil For Treatment Of Multiple Myeloma

EP4630000A1 · Kadmon Corporation, LLC · Mar 18, 2026
Publication

Dissociable Envelope Binding Proteins And Uses Thereof

EP4630444A1 · CSL Behring LLC · Mar 18, 2026
Publication

Antibodies Against Edil3 And Methods Of Use Thereof

EP4630450A1 · Dana Farber Cancer Institute, Inc. · Mar 18, 2026
Publication

New Peptides And Use Thereof As Delivery Systems For Internalization Of Molecules Of Interest Into Target Cells

EP4630059A1 · Université Grenoble Alpes · Mar 18, 2026
Publication

Adsorbent And Methods Of Manufacturing And Using The Same

EP4630158A1 · Astrea UK Services Limited · Mar 18, 2026
Publication

Binding Molecule

EP4630448A1 · Strike Pharma AB · Mar 18, 2026
Publication

Gp130 Antigen Binding Molecules

EP4630453A1 · VVB Bio Pte. Ltd. · Mar 18, 2026
Publication

Antibodies Targeting Itga2 And Antibody Drug Conjugates Comprising Same

EP4545563A1 · Foreseen Technology (Beijing) Co., Ltd. · Mar 18, 2026
Publication

Preparation Method For And Use Of Her2 Nanobody And Conjugate

EP2024001510A1 · Fudan University · Mar 18, 2026
Publication

Anti Ilt7 Binding Agents For The Treatment And Prevention Of Myositis

EP4634225A1 · Viela Bio, Inc. · Mar 18, 2026
Publication

Anti Gdf 15 Antibody For Neoadjuvant Therapy Of Cancer

EP4634222A1 · CatalYm GmbH · Mar 18, 2026
Publication

Cd47 Blocking Agent And Anti Bcma / Anti Cd3 Bispecific Antibody Combination Therapy

EP4630121A1 · Pfizer Inc. · Mar 18, 2026
Publication

Arginine Wash In Protein Purification

EP4634201A1 · H. Lundbeck A/S · Mar 18, 2026
Publication

Chimeric Antigen Receptor

EP4630042A1 · Université de Genève · Mar 18, 2026
Publication

Extracellular Matrix Binding Compounds For The Localized Loading Of Therapeutic Or Diagnostic Agents

EP4630443A1 · Kamino ApS · Mar 18, 2026
Publication

Anti Huntingtin Antibodies

EP4630449A1 · Alchemab Therapeutics Ltd. · Mar 18, 2026
Publication

Polypeptide Having Lysozyme Activity And Polynucleotides Encoding Same

EP4629838A1 · Novozymes A/S · Mar 18, 2026
Publication

The Fgf 2 Polypeptides With Improved Stability, The Process For Preparing The Fgf 2 Polypeptides And Use Thereof

EP4619418A1 · BTL Healthcare Technologies a.s. · Mar 18, 2026
Publication

Recombinant Receptors Binding B Cell Activation Factor Receptor And Uses Thereof

EP4532534A1 · Seattle Children's Hospital d/b/a Seattle Children's Research Institute · Mar 18, 2026
Publication

Recombinant Fusion Protein Targeting Pd L1 And Vegf, And Preparation And Use Thereof

EP4534564A1 · ImmuneOnco Biopharmaceuticals (Shanghai) Inc. · Mar 18, 2026
Publication

Composite Aids Vaccine Generating Anti Hiv Specific Neutralizing Antibodies And/Or Anti Hiv Cytotoxic T Cells

EP4630027A1 · DYS-Immune Therapeutics · Mar 18, 2026
Publication

Dosing Regimens Using Heterodimeric Relaxin Fusions

EP4630036A1 · Astrazeneca AB · Mar 18, 2026
Publication

Combination For Treatment And Prevention Of Cancer

EP4630054A1 · Hummingbird Bioscience Pte. Ltd. · Mar 18, 2026
Publication

Method Of Treating Ulcerative Colitis With Anti Il23 Specific Antibody

EP4623001A1 · Janssen Biotech, Inc. · Mar 18, 2026
Publication

Process For Producing A Lactoferrin Containing Product

EP4629833A1 · FrieslandCampina Nederland B.V. · Mar 18, 2026
Publication

Ligands Specific For Asct1

EP4630804A1 · Metafora Biosystems · Mar 18, 2026
Publication

Vaccines Against Protein Tyrosine Phosphatase Receptor Type Z1 (Ptprz1) Positive Tumors

EP4630040A1 · Altevax · Mar 18, 2026
Publication

Selective Regulatory Gene (Srg) System For Genetically Modified Immune Cell Therapy

EP4502162A1 · Jichi Medical University · Mar 18, 2026
Publication

Method For Separating Beta Xylosidase Enzyme From An Enzyme Mixture

EP4630545A1 · IFP Energies nouvelles · Mar 18, 2026
Publication

Ptk7 Binding Protein And Use Thereof

EP4573129A1 · Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Mar 18, 2026
Publication

Methods, Device, Kit And Compositions For Detecting Feline Lungworm

EP4499119A2 · IDEXX Laboratories, Inc. · Mar 18, 2026
Publication

Monoclonal Antibodies For Targeting The Cardiac Conduction System

EP4496817A2 · The Board of Trustees of the Leland Stanford Junior University · Mar 18, 2026
Publication

Genetically Modified Microorganism For Producing 3 Hydroxyadipic Acid And/Or 3 Oxoadipic Acid And Production Method For Said Chemical Products

EP4497819A1 · Toray Industries, Inc. · Mar 18, 2026
Publication

Simulated Moving Bed Chromatographic Separation Method And Simulated Moving Bed Chromatographic Separation System

EP4498078A1 · Organo Corporation · Mar 18, 2026
Publication

Anti Her2/Anti Cd47 Molecules And Uses Thereof

EP4499711A1 · WuXi Biologics Ireland Limited · Mar 18, 2026
Publication

Anti Folate Receptor Alpha Antibodies And Methods Of Use

EP4499697A1 · Zymeworks BC Inc. · Mar 18, 2026
Publication

Synthetic Peptide For Use In An Immunomolecular Assay

EP4630441A1 · bioMérieux · Mar 18, 2026
Publication

Binding Molecules Specific To Human Epidermal Growth Factor Receptor 2

EP4504796A1 · The National Institute for Biotechnology in the Negev Ltd. · Mar 18, 2026
Publication

Combination Of Multi Specific Molecule And Immune Checkpoint Inhibitor

EP4494655A1 · Daiichi Sankyo Company, Limited · Mar 18, 2026
Publication

Stable High Concentration Arginine Formulations Containing Pd 1 Antibody And Methods Of Use Thereof

EP4507726A1 · BeiGene Switzerland GmbH · Mar 18, 2026
Publication

Methods And Systems For Allele Typing

EP4504973A2 · Guardant Health, Inc. · Mar 18, 2026
Publication

Avian Influenza Vaccines And Methods Of Making Same

EP4504755A1 · The United States of America, as Represented by the Secretary of Agriculture · Mar 18, 2026
Publication

Claudin18.2 Humanized Antibody And Application Thereof

EP4495140A1 · Sunshine Lake Pharma Co., Ltd. · Mar 18, 2026
Publication

Pharmaceutical Composition Of Anti Tim 3 Antibody And Hypomethylating Agent

EP4494654A1 · Nanjing Shunxin Pharmaceuticals Co., Ltd. of Chiatai Tianqing Pharmaceutical Group · Mar 18, 2026
Publication

Multiplex Gene Edited Cells For Cd70 Directed Cancer Immunotherapy

EP4482872A2 · Nkarta, Inc. · Mar 18, 2026
Publication

A Novel Protein Composition And Their Use In Formulating Dairy Products

EP4490169A1 · PHYX44 Labs Private Limited · Mar 18, 2026
Publication

Regulatory T Cells With Chimeric Antigen Receptor Targeting Co Stimulatory Molecules To Prevent And/Or Treat Inflammatory Conditions

EP4486764A2 · The Children's Medical Center Corporation · Mar 18, 2026
Publication

Heterodimeric Polypeptide Complexes Comprising Il 15 Variants And Uses Thereof

EP4486795A1 · WuXi Biologics Ireland Limited · Mar 18, 2026
Publication

Antibodies And Variants Thereof Against Human B7 H3

EP4482874A1 · Nanjing Probio Biotech Co., Ltd. · Mar 18, 2026
Publication

Use Of 5 (2 ((5 (4 (Dimethylamino)piperidin 1 Yl)pyridin 2 Yl)amino) 5 Fluoropyrimidin 4 Yl) N,4 Dimethylthiazol 2 Amine In Combination Therapies For Cancer

EP4493192A1 · Aucentra Therapeutics Pty Ltd · Mar 18, 2026
Publication

Systems And Methods For Genetic Modulation To Treat Ocular Diseases

EP4490295A1 · Epicrispr Biotechnologies, Inc. · Mar 18, 2026
Publication

Lysine Free Ubiquibody Variants For Long Lived Intracellular Protein Silencing

EP4490200A2 · Cornell University · Mar 18, 2026
Publication

Systems And Methods For Genetic Modulation To Treat Liver Disease

EP4490294A1 · Epicrispr Biotechnologies, Inc. · Mar 18, 2026
Publication

Compositions And Methods For Cancer Immunotherapy

EP4475865A2 · Mural Oncology, Inc. · Mar 18, 2026
Publication

Mrna Expression And Delivery Systems

EP4476252A2 · Iowa State University Research Foundation, Inc. · Mar 18, 2026
Publication

Multispecific Binding Agents And Uses Thereof

EP4475886A2 · Exelixis, Inc. · Mar 18, 2026
Publication

Peptide Binding To Mesothelin, And Use Thereof

EP4477660A1 · Kyungpook National University Industry-Academic Cooperation Foundation · Mar 18, 2026
Publication

Antigen Binding Protein And Use Thereof

EP4471064A1 · Minghui Pharmaceutical (Hangzhou) Limited · Mar 18, 2026
Publication

Method For Regulating And Controlling Heterologous Synthetic Flavonoid Compound And Use Thereof

EP4467651A1 · CAS Center for Excellence in Molecular Plant Sciences · Mar 18, 2026
Publication

Production Of Rna Polynucleotides Encoding Picornavirus

EP4514822A2 · ElevateBio Technologies, Inc. · Mar 18, 2026
Publication

Tdt Specific Chimeric Receptors And Methods Of Their Use

EP4514833A2 · Baylor College of Medicine · Mar 18, 2026
Publication

Gd2 Chimeric Antigen Receptor And Use Thereof

EP4486790A1 · Beijing Meikang Geno-Immune Biotechnology Co., Ltd · Mar 18, 2026
Publication

Purification Process

EP4561722A2 · GlaxoSmithKline Biologicals S.A. · Mar 18, 2026
Publication

Anti Alarmin Binding Molecules And Treatment Of Pneumonitis

EP4482522A2 · Lanier Biotherapeutics, Inc. · Mar 18, 2026
Publication

Modified Bacterium With Anti Tumour Activity

EP4464773A1 · Shenzhen Synthetica Pioneering Co., Ltd. · Mar 18, 2026
Publication

Modified Amino Acids And Uses Thereof

EP4543901A2 · University of Strathclyde · Mar 18, 2026
Publication

Dosage Regimen For A Combination Therapy Consisting Oftcr Engineered T Cells In Combination With A Pd 1 Axis Binding Antagonist

EP4539874A1 · USWM CT, LLC · Mar 18, 2026
Publication

Vaccine Against Leptospirosis

EP4469470A2 · Yale University · Mar 18, 2026
Publication

Compositions, Devices And Methods For Treating Cns Disorders

EP4469490A2 · Sigilon Therapeutics, Inc. · Mar 18, 2026
Publication

Use Of Myostatin Inhibitor For Treating Spinal Muscular Atrophy

EP4518970A2 · Scholar Rock, Inc. · Mar 18, 2026
Publication

Vectorized Anti Complement Antibodies And Complement Agents And Administration Thereof

EP4518972A2 · RegenxBio Inc. · Mar 18, 2026
Publication

Combotope Antibody Libraries

EP2024193794A1 · Mar 18, 2026
Publication

Anti Ed A Antibodies For The Treatment Of Pulmonary Hypertension

EP4493210A1 · Universitätsklinikum Jena · Mar 18, 2026
Publication

Stable Aqueous Formulation Of An Anti Adrenomedullin (Adm) Antibody Or Anti Adm Antibody Fragment

EP4493588A1 · AdrenoMed AG · Mar 18, 2026
Publication

Microchip Capillary Electrophoresis Assays And Reagents

EP4317959A2 · Regeneron Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Gas Permeable Sealing Member For Drug Container And Methods Of Assembly

EP4292576A2 · Amgen Inc. · Mar 18, 2026
Publication

Novel T Cell Receptor

EP4472742A1 · University College Cardiff Consultants Limited · Mar 18, 2026
Publication

Use Of The Cd2 Signaling Domain In Second Generation Chimeric Antigen Receptors

EP4275699A2 · The Trustees of the University of Pennsylvania · Mar 18, 2026
Publication

Sulfur (Vi) Fluoride Compounds And Their Use In Click Reaction

EP4295841A2 · The Scripps Research Institute · Mar 18, 2026
Publication

Stabilized Polypeptides

EP4541814A1 · Cytiva BioProcess R&D AB · Mar 18, 2026
Publication

Fusion Protein For Affinity Capture

EP4541444A1 · Cytiva BioProcess R&D AB · Mar 18, 2026
Publication

Formulations Of Guanylate Cyclase C Agonists And Methods Of Use

EP4309673A2 · Bausch Health Ireland Limited · Mar 18, 2026
Publication

Peptide Having Effects Of Increasing Telomerase Activity And Extending Telomere, And Composition Containing Same

EP4272829A2 · Gemvax & Kael Co., Ltd. · Mar 18, 2026
Publication

Inducible Coexpression System

EP4273257A2 · ABSCI Corporation · Mar 18, 2026
Publication

Identification Of Common Tumor Specific T Cell Receptors And Antigens

EP4249592A2 · Boehringer Ingelheim International GmbH · Mar 18, 2026
Publication

Methods Of Altering Gene Expression By Perturbing Transcription Factor Multimers That Structure Regulatory Loops

EP4249501A2 · Whitehead Institute for Biomedical Research · Mar 18, 2026
Publication

Methods For Treatment Of Ornithine Transcarbamylase (Otc) Deficiency

EP4466367A1 · The Trustees of The University of Pennsylvania · Mar 18, 2026
Publication

Development Of Novel Pdl1 Single Domain Antibody

EP4458855A1 · Persongen Biotherapeutics (Suzhou) Co., Ltd. · Mar 18, 2026
Publication

Anti Coronavirus Polypeptide, And Derivatives Thereof And Application Thereof

EP4458844A1 · Institute Of Microbiology, Chinese Academy Of Sciences · Mar 18, 2026
Publication

Peptide For Cartilage Regeneration, And Uses Thereof

EP4631957A1 · Caregen Co., Ltd. · Mar 18, 2026
Publication

Peptide For Cartilage Regeneration, And Uses Thereof

EP4631969A1 · Caregen Co., Ltd. · Mar 18, 2026
Publication

Peptide For Cartilage Regeneration, And Uses Thereof

EP4631965A1 · Caregen Co., Ltd. · Mar 18, 2026
Publication

Peptide For Cartilage Regeneration, And Uses Thereof

EP4631968A1 · Caregen Co., Ltd. · Mar 18, 2026
Publication

Peptide For Cartilage Regeneration, And Uses Thereof

EP4631964A1 · Caregen Co., Ltd. · Mar 18, 2026
Publication

Peptide For Cartilage Regeneration, And Uses Thereof

EP4631967A1 · Caregen Co., Ltd. · Mar 18, 2026
Publication

Peptide For Cartilage Regeneration, And Uses Thereof

EP4631963A1 · Caregen Co., Ltd. · Mar 18, 2026
Publication

Peptide For Cartilage Regeneration, And Uses Thereof

EP4631962A1 · Caregen Co., Ltd. · Mar 18, 2026
Publication

Peptide For Cartilage Regeneration, And Uses Thereof

EP4631961A1 · Caregen Co., Ltd. · Mar 18, 2026
Publication

Peptide For Cartilage Regeneration, And Uses Thereof

EP4631958A1 · Caregen Co., Ltd. · Mar 18, 2026
Publication

Peptide Having Inhibitory Activity Against Osteoclast Differentiation, And Use Thereof

EP4631960A1 · Caregen Co., Ltd. · Mar 18, 2026
Publication

Peptide Having Activity Of Improving State Of Skin, And Use Thereof

EP4631491A1 · Caregen Co., Ltd. · Mar 18, 2026
Publication

Use Of Timp3 Recombinant Protein In Preparing Formulation For Inhibiting Hypertension Related Clear Cell Carcinoma Of Kidney

EP2024055443A1 · Shenzhen Institutes of Advanced Technology · Mar 18, 2026
Publication

Antigen Peptide Targeting Flt3 D835 Mutation And Use Thereof In Tumor Immunotherapy

EP2024031811A1 · Ruijin Hospital, Shanghai Jiaotong University School of Medicine · Mar 18, 2026
Publication

Activin Actrii Antagonists And Uses For Treating Myelodysplastic Syndrome

EP4233889A2 · Celgene Corporation · Mar 18, 2026
Publication

Methods And Compositions For Altering A Tumor Microbiome

EP4448111A1 · Board of Regents, The University of Texas System · Mar 18, 2026
Publication

Pseudotyped Viral Particles, Compositions Comprising The Same, And Uses Thereof

EP4448550A2 · Interius Biotherapeutics, Inc. · Mar 18, 2026
Publication

Cd28 Binding Antibodies And Antigen Binding Fragments Thereof

EP4448581A2 · Biolegend, Inc. · Mar 18, 2026
Publication

Therapeutic Single Domain Antibody

EP4392459A2 · Singh Biotechnology, LLC · Mar 18, 2026
Publication

Compositions And Methods For Anti Virus Chimeric Antigen Receptor

EP4388017A1 · Rudd, Christopher E. · Mar 18, 2026
Publication

Elongate Force Sensor Assembly With Throughgoing Bore

EP4380958A1 · Vishay Advanced Technologies, Ltd. · Mar 18, 2026
Publication

Anti Human Leukocyte Antigen G Nanobody, And Preparation Method Therefor And Use Thereof

EP2024108568A1 · Shenzhen Institutes of Advanced Technology · Mar 18, 2026
Publication

Method For Enhancing Broad Spectrum Property Of Vaccine Against Covid 19 Mutant Strains, And Broad Spectrum Covid 19 Vaccine

EP2024103431A1 · Sun Yat-Sen University · Mar 18, 2026
Publication

Monoclonal Antibody Against Hla G1, G2, G5 And Hla G6 Isomeric Molecules And Use Thereof

EP4501961A1 · Taizhou Enze Medical Center (Group) · Mar 18, 2026
Publication

Integration Of Large Nucleic Acids Into Genomes

EP4493706A1 · THE REGENTS OF THE UNIVERSITY OF CALIFORNIA · Mar 18, 2026
Publication

Cell Penetrating Polypeptides (Cpps) And Their Use In Human Therapy

EP4448556A1 · RDP Pharma AG · Mar 18, 2026
Publication

Stable Compositions Of Foxy 5 Hexapeptide With High Solubility

EP4444353A1 · Wntresearch AB · Mar 18, 2026
Publication

Peptide And Composition

EP4368629A1 · OSAKA UNIVERSITY · Mar 18, 2026
Publication

Sapovirus Vaccines

EP4362975A2 · VST LLC dba Medgene Labs · Mar 18, 2026
Publication

Antibody Binding To Bcma And Use Thereof

EP4446341A1 · Innovent Biologics (Suzhou) Co., Ltd. · Mar 18, 2026
Publication

A Maps Vaccine Targeting Salmonella Enterica Serovars

EP4440606A1 · The Children's Medical Center Corporation · Mar 18, 2026
Publication

Methods Of Generating Self Replicating Rna Molecules

EP4441075A1 · Replicate Bioscience, Inc. · Mar 18, 2026
Publication

Retargeted Retroviral Vectors Resistant To Vaccine Induced Neutralization And Compositions Or Methods Of Use Thereof

EP4433579A2 · The Broad Institute, Inc. · Mar 18, 2026
Publication

Retargeted Retroviral Vectors And Compositions Or Methods Of Use Thereof

EP4433578A1 · The Broad Institute, Inc. · Mar 18, 2026
Publication

Peptides And Uses Thereof

EP4433495A1 · Preveceutical Medical Inc. · Mar 18, 2026
Publication

Bcma Targeting Chimeric Antigen Receptor And Use Thereof

EP4435012A1 · Juventas Co., Ltd. · Mar 18, 2026
Publication

Combination Therapy Of Claudin 18.2 Antagonist And Pd 1/Pd L1 Axis Inhibitor

EP4433510A1 · Suzhou Transcenta Therapeutics Co., Ltd. · Mar 18, 2026
Publication

Relaxin 2 Fusion Protein Analogs And Methods Of Using Same

EP4429694A2 · Tectonic Operating Company, Inc. · Mar 18, 2026
Publication

Antibodies Binding Cldn18.2 And Uses Thereof

EP4419550A1 · Biosion, Inc. · Mar 18, 2026
Publication

Recombinant Newcastle Disease Virus Expressing Spike Protein Of Sars Cov 2 Delta Variant And Uses Thereof

EP4408463A2 · Icahn School of Medicine at Mount Sinai · Mar 18, 2026
Publication

Compositions, Kits, And Methods For Duplex Immunoassay For Anti Sars Cov 2 Antibodies

EP4408880A1 · Siemens Healthcare Diagnostics, Inc. · Mar 18, 2026
Publication

Peptide Having Anti Aging Activity, And Use Thereof

EP4410817A1 · Caregen Co., Ltd. · Mar 18, 2026
Publication

Compositions And Methods For Multiplex Base Editing In Hematopoietic Cells

EP4401744A1 · Vor Biopharma Inc. · Mar 18, 2026
Publication

Novel Protein And Pharmaceutical Composition Comprising Same For Prevention Or Treatment Of Cancer

EP4403567A1 · Cellemedy Co., Ltd · Mar 18, 2026
Publication

Use Of Anti Il 1 Beta Antibodies

EP4218815A2 · Novartis AG · Mar 18, 2026
Publication

Dimeric Collagen Hybridizing Peptides And Methods Of Use Thereof

EP4355769A1 · University of Utah Research Foundation · Mar 18, 2026
Publication

Inhibitory Peptides For The Diagnostic And/Or Treatment Of Tauopathies

EP4441082A1 · Université de Rennes · Mar 18, 2026
Publication

Compositions And Methods For Treating Neurofibromatic Disorders

EP4352079A1 · NF2 Therapeutics, Inc. · Mar 18, 2026
Publication

Compositions And Methods For Treating Interleukin 7 Receptor Deficiency

EP4426726A1 · The Children's Hospital Of Philadelphia · Mar 18, 2026
Publication

Methods Of Treating Cancer

EP4426360A1 · Fusion Pharmaceuticals Inc. · Mar 18, 2026
Publication

Betacoronavirus Attenuated Strain

EP4431599A1 · The Research Foundation for Microbial Diseases of Osaka University · Mar 18, 2026
Publication

Bcma Monoclonal Antibody And The Antibody Drug Conjugate

EP4426741A1 · Hangzhou DAC Biotech Co., Ltd. · Mar 18, 2026
Publication

Reagent Containing Humanized Antibody

EP4372009A1 · Denka Company Limited · Mar 18, 2026
Publication

Cancer Treatment Combinations

EP4373525A1 · Viracta Subsidiary, Inc. · Mar 18, 2026
Publication

Vedolizumab Formulation

EP4456917A1 · Polpharma Biologics S.A. · Mar 18, 2026
Publication

High Efficency Production Of Cannabigerolic Acid And Cannabidiolic Acid

EP4370652A1 · Amyris, Inc. · Mar 18, 2026
Publication

Personalized Immunotherapy Using Intestinal Metabolites

EP4329787A1 · Infinant Health, Inc · Mar 18, 2026
Publication

Antibodies For The Treatment And Prevention Of Covid 19 And Emerging Variants

EP4330279A2 · The Trustees of Columbia University in the City of New York · Mar 18, 2026
Publication

Novel Anti Cd5 Chimeric Antigen Receptor And Immune Cell Expressing Same

EP4332118A1 · Korea Research Institute of Bioscience and Biotechnology · Mar 18, 2026
Publication

Coronavirus Vaccines And Methods Of Use

EP4404960A1 · BioNTech SE · Mar 18, 2026
Publication

Engineering B Cell Based Protein Factories To Treat Serious Diseases

EP4326290A2 · Walking Fish Therapeutics, Inc. · Mar 18, 2026
Publication

Anti Inflammatory Siglec Proteins And Methods Of Making And Using Same

EP4323378A2 · Palleon Pharmaceuticals Inc. · Mar 18, 2026
Publication

Dna Binding Proteins For Regulating Gene Expression

EP4323515A1 · Altius Institute For Biomedical Sciences · Mar 18, 2026
Publication

Cell Penetrating Peptide, Anti Cancer Peptide, And Pharmaceutical Composition For Preventing Or Treating Cancer, Comprising Same

EP4324841A1 · Onecuregen Co., Ltd. · Mar 18, 2026
Publication

Polynucleotides Capable Of Enhanced Protein Expression And Uses Thereof

EP4323382A1 · Biorchestra Co., Ltd. · Mar 18, 2026
Publication

Compositions And Methods For Treating Pulmonary Hypertension

EP4358991A1 · Acceleron Pharma, Inc. · Mar 18, 2026
Publication

Antiviral Structurally Stapled Sars Cov 2 Peptide Cholesterol Conjugates And Uses Thereof

EP4399220A1 · Dana-Farber Cancer Institute, Inc. · Mar 18, 2026
Publication

Dosing Of Bispecific T Cell Engager

EP4319815A1 · Anji Bruno, LLC · Mar 18, 2026
Publication

Bispecific Molecules And Related Compositions And Methods

EP4314050A1 · The Board of Trustees of the Leland Stanford Junior University · Mar 18, 2026
Publication

Staphylococcus Aureus Vaccine Compositions

EP4313303A1 · Janssen Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Compounds And Methods For Liquid Phase Synthesis

EP4392404A1 · Eli Lilly and Company · Mar 18, 2026
Publication

Compounds For Regulating Trained Immunity, And Their Methods Of Use

EP4308105A1 · Trained Therapeutix Discovery, Inc. · Mar 18, 2026
Publication

Antibodies Targeting Pulmonary Nodule Specific Biomarkers And Uses Thereof

EP4423134A1 · Biodesix, Inc. · Mar 18, 2026
Publication

Reconstitution And Uses Of Flavivirus Epitopes

EP4347622A1 · Ramot at Tel-Aviv University Ltd. · Mar 18, 2026
Publication

Engineered Antimicrobial Peptides And Usage Thereof

EP4337321A2 · University of Pittsburgh - of the Commonwealth System of Higher Education · Mar 18, 2026
Publication

Immunomodulation Of Tumor Microenvironment

EP4340682A1 · Genkin, Dmitry Dmitrievich · Mar 18, 2026
Publication

Polyclonal Antibodies To Treat Respiratory Syncytial Virus

EP4351646A1 · Lactiga, Inc. · Mar 18, 2026
Publication

Indications For Anti Prame Binders

EP4412642A2 · immatics biotechnologies GmbH · Mar 18, 2026
Publication

Peptide Fc Fusions For Treating Amyloid Disorders

EP4333871A1 · University of Tennessee Research Foundation · Mar 18, 2026
Publication

Cannabis Plants Exhibiting Powdery Mildew Resistance And Methods For Obtaining Same

EP4334478A1 · Canopy Growth Corporation · Mar 18, 2026
Publication

Biomarkers For Cancer Treatment

EP4291902A2 · Foundation Medicine, Inc. · Mar 18, 2026
Publication

Drug Conjugate Of Glucocorticoid Receptor Agonist, And Application Thereof In Medicine

EP4289857A1 · Shanghai Senhui Medicine Co., Ltd. · Mar 18, 2026
Publication

Chimeric Antigen Receptor With Endogenous Protein Molecule Replacing Single Domain Antibody

EP4289867A1 · Zhejiang University · Mar 18, 2026
Publication

Highly Specific Rabbit Single Domain Antibodies For Drug Delivery In Immunotherapy Applications

EP4367146A1 · Technophage, Investigação e Desenvolvimento em Biotecnologia, SA · Mar 18, 2026
Publication

Epigenetic Gene Regulation To Treat Neurological Diseases And Pain

EP4284927A2 · Navega Therapeutics, Inc. · Mar 18, 2026
Publication

Compositions Comprising Hiv Envelopes To Induce Hiv 1 Antibodies

EP4284427A1 · Duke University · Mar 18, 2026
Publication

Platelet Alpha Granules For Delivery Of Multiple Proteins

EP4284917A2 · Longitude Therapeutics S.r.l. · Mar 18, 2026
Publication

Antibody Drug Conjugate, Preparation Method Therefor And Application Thereof

EP4331616A1 · Tsinghua University · Mar 18, 2026
Publication

Assay Method For Relaxin

EP4402474A1 · Bellylabs OY · Mar 18, 2026
Publication

The Polarity And Specificity Of Sars Cov2 Specific T Lymphocyte Responses As A Biomarker Of Disease Susceptibility

EP4330674A1 · Institut Gustave-Roussy · Mar 18, 2026
Publication

Vaccines For The Treatment And Prevention Of Zoonotic Infections

EP4301406A1 · Longhorn Vaccines and Diagnostics, LLC · Mar 18, 2026
Publication

Blackleg Resistant Plants And Methods For The Identification Of Blackleg Resistant Plants

EP4373260A1 · BASF Agricultural Solutions US LLC · Mar 18, 2026
Publication

Modulation Of Antibody Dependent Cellular Cytotoxicity

EP4326333A1 · Seagen Inc. · Mar 18, 2026
Publication

Cyclic Peptide Immunomodulators

EP4323380A2 · Bristol-Myers Squibb Company · Mar 18, 2026
Publication

Camptothecine Antibody Drug Conjugates And Methods Of Use Thereof

EP4277629A1 · R.P. Scherer Technologies, LLC · Mar 18, 2026
Publication

Methods For Selecting Watermelon Plants And Plant Parts Comprising A Modified Dwarf14 Gene

EP4362660A1 · Nunhems B.V. · Mar 18, 2026
Publication

Combination Of Deoxyribonuclease Enzyme And Cell Therapies For Treatment Of Cancer

EP4274585A1 · CLS Therapeutics Limited · Mar 18, 2026
Publication

Aav8 Capsid Variants With Enhanced Liver Targeting

EP4330270A2 · Takeda Pharmaceutical Company Limited · Mar 18, 2026
Publication

Subset Optimized Chimeric Antigen Receptor Containing Cells

EP4205749A1 · Novartis AG · Mar 18, 2026
Publication

Methods Of Producing Long Acting Ctp Modified Polypeptides

EP4212546A1 · OPKO Biologics Ltd. · Mar 18, 2026
Publication

Protein Comprising Nc 1 For Treating Angiogenesis Related Diseases

EP4215206A1 · Heidelberg Biotech GmbH · Mar 18, 2026
Publication

Markers Of Autoimmune Diseases

EP4327101A1 · SORBONNE UNIVERSITE · Mar 18, 2026
Publication

Non Viral Dna Vectors Expressing Anti Coronavirus Antibodies And Uses Thereof

EP4329884A1 · Generation Bio Co. · Mar 18, 2026
Publication

Antibody Therapeutics That Bind Cd38

EP4180058A1 · Vivasor, Inc. · Mar 18, 2026
Publication

Anti Viral Therapeutic

EP4284827A1 · University College Cardiff Consultants Limited · Mar 18, 2026
Publication

Acebutolol Hydrochloride For Use In Treating Psoriasis

EP4342462A1 · Sun, Liangdan · Mar 18, 2026
Publication

Manipulation Of Immunoglobulin Gene Diversity And Multi Antibody Therapeutics

EP4091442A1 · Kymab Limited · Mar 18, 2026
Publication

Compositions And Methods For Immune Repertoire Sequencing

EP4050113A1 · Life Technologies Corporation · Mar 18, 2026
Publication

Antibodies Specifically Binding Pd 1 And Their Uses

EP4046655A1 · Janssen Biotech, Inc. · Mar 18, 2026
Publication

Generation Of Haploid Plants

EP4144850A1 · KWS SAAT SE & Co. KGaA · Mar 18, 2026
Publication

Compositions For Rejuvenating Skeletal Muscle Stem Cells

EP4140497A1 · President and Fellows of Harvard College · Mar 18, 2026
Publication

Water Efficient Cucurbitaceae

EP4274434A1 · Origene Seeds Ltd. · Mar 18, 2026
Publication

Tnf Alpha And Ngf Antibodies For Veterinary Use

EP4263603A2 · Elanco US Inc. · Mar 18, 2026
Publication

Desmoglein 2 Directed Chimeric Antigen Receptor (Car) Constructs And Methods Of Use

EP4255484A1 · Thomas Jefferson University · Mar 18, 2026
Publication

Generalized Scaffolds For Polypeptide Display And Uses Thereof

EP4256568A1 · iBio, Inc. · Mar 18, 2026
Publication

Shape Memory Silk Materials

EP4116318A1 · Tufts University · Mar 18, 2026
Publication

Long Acting Compstatin Analogs And Uses Thereof

EP4105224A1 · Apellis Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Antibodies Binding Cd24, Preparation And Use Thereof

EP4166196A1 · ImmuneOnco Biopharmaceuticals (Shanghai) Inc. · Mar 18, 2026
Publication

Antibodies Binding Cd70, Preparation And Use Thereof

EP4166571A1 · ImmuneOnco Biopharmaceuticals (Shanghai) Inc. · Mar 18, 2026
Publication

Anti Vegf Anti Pd L1 Bispecific Antibody, Pharmaceutical Composition Of Same, And Uses Thereof

EP4209513A1 · Biotheus Inc. · Mar 18, 2026
Publication

Compositions And Methods For Treating Mesothelin Positive Cancers

EP4100028A1 · A2 Biotherapeutics, Inc. · Mar 18, 2026
Publication

Anti Cd73 Antibody And Use Thereof

EP4197555A1 · Akeso Biopharma, Inc. · Mar 18, 2026
Publication

Humanized Antibody, Chimeric Antigen Receptor, Nucleic Acid, Vector, Cell And Use

EP4190808A1 · Shenzhen Immunofoco Biotechnology Co., Ltd. · Mar 18, 2026
Publication

Methods And Compositions For Making Antibody Libraries And Antibodies Isolated From The Same

EP4192858A1 · Integral Molecular, Inc. · Mar 18, 2026
Publication

Therapeutic Targeting Of Phosphate Dysregulation In Cancer Via The Xpr1:Kidins220 Protein Complex

EP4192486A1 · The Broad Institute, Inc. · Mar 18, 2026
Publication

Polypeptides Rv3 And Rv4 Having Anti Aging Function And Applications Thereof

EP4190798A1 · Nanjing Anji Biological Technology Co., Ltd · Mar 18, 2026
Publication

Formulation Of Novel Bispecific Anti Cd3/Cd20 Polypeptide Complex

EP4190352A1 · CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. · Mar 18, 2026
Publication

Antivirus Proteins Having A Kringle 5 Subunit

EP4319878A1 · CREATIVE BIOTHERAPEUTICS, LLC · Mar 18, 2026
Publication

Monoclonal Antibody Specifically Binding To Sugar Chain In Which A Terminal Sialic Acid Residue Is Bound To Galactose With ?2,6 Linkage, And Method For Measuring Sugar Chain In Which Terminal Sialic Acid Residue Is Bound To Galactose With ?2,6 Linkage

EP4310100A1 · HIROSAKI UNIVERSITY · Mar 18, 2026
Publication

Target Cell Restricted, Costimulatory, Bispecific And Bivalent Anti Cd28 Antibodies

EP4240762A1 · Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts · Mar 18, 2026
Publication

Linear Apelin Receptor Agonists

EP4225773A1 · Nxera Pharma UK Limited · Mar 18, 2026
Publication

Triple Combination Therapy For Enhancing Cancer Cell Killing In Cancers With Low Immunogenicity

EP4146216A1 · Beyondspring Pharmaceuticals Inc. · Mar 18, 2026
Publication

Precision Dosing Regimen

EP4142755A1 · Children's Hospital Medical Center · Mar 18, 2026
Publication

Novel Therapy For Acute Damage To Lung Tissue

EP4138916A1 · Remodeless CV Ltd. · Mar 18, 2026
Publication

Single Variable Domain Antibody Targeting Human Programmed Death Ligand 1 (Pd L1) And Derivative Thereof

EP4144758A1 · Mabwell (Shanghai) Bioscience Co., Ltd. · Mar 18, 2026
Publication

Recombinant Sars Cov 2 Spike Protein Subunits, Expression And Uses Thereof

EP4208198A2 · Hawaii Biotech, Inc. · Mar 18, 2026
Publication

Combination Of A Sting Agonist And A Complex Comprising A Cell Penetrating Peptide, A Cargo And A Tlr Peptide Agonist

EP4228681A1 · Boehringer Ingelheim International GmbH · Mar 18, 2026
Publication

Treating Autoimmune Diseases With Genetically Modified Cells

EP4132545A1 · Wallkill Biopharma, Inc. · Mar 18, 2026
Publication

Methods And Treatment Involving Excess Free Light

EP4126945A2 · Avalo Therapeutics, Inc. · Mar 18, 2026
Publication

Antibody Drug Conjugates

EP4240488A1 · Takeda Pharmaceutical Company Limited · Mar 18, 2026
Publication

Compositions For And Methods Of Enhancing Tissue Regeneration

EP4222163A1 · Duke University · Mar 18, 2026
Publication

Recombinant Adeno Associated Viruses With Enhanced Liver Tropism And Uses Thereof

EP4244360A1 · Beijing SoloBio Genetechnology Company Ltd. · Mar 18, 2026
Publication

Polypeptides For Use In The Treatment And Prevention Of Neurodegenerative Diseases

EP4232066A1 · Immune System Key Ltd. · Mar 18, 2026
Publication

Treatment Of Inflammatory Diseases With Peptides And Pharmaceutical Compositions

EP4114430A2 · YUYU Pharma, Inc. · Mar 18, 2026
Publication

Combination Of Merestinib With Ly2584702 For The Treatment Of Glioblastoma

EP4117787A1 · University of Cincinnati · Mar 18, 2026
Publication

Zika Virus Polypeptides

EP4114844A1 · Mayo Foundation for Medical Education and Research · Mar 18, 2026
Publication

Anti Tumor Composition

EP4112065A1 · SPH Sine Pharmaceutical Laboratories Co., Ltd · Mar 18, 2026
Publication

Diamine Linked Receptor Specific Cyclic Peptides

EP4100040A1 · Boehringer Ingelheim International GmbH · Mar 18, 2026
Publication

Pharmaceutical Use Of Ketoamide Based Compound

EP4098258A1 · Shanghai Institute of Materia Medica, Chinese Academy of Sciences · Mar 18, 2026
Publication

Protein Degradation

EP4139445A1 · University of Dundee · Mar 18, 2026
Publication

Novel Combination For The Treatment Of Aids

EP4138910A1 · 21C BIO · Mar 18, 2026
Publication

Antibody Molecule Drug Conjugates And Uses Thereof

EP4126064A1 · Visterra, Inc. · Mar 18, 2026
Publication

Modified Fc Regions

EP4107179A1 · Zoetis Services LLC · Mar 18, 2026
Publication

Bispecific Factor Viii Mimetic Antibodies

EP4097141A1 · Novo Nordisk A/S · Mar 18, 2026
Publication

Alk5 Inhibitor Conjugates And Uses Thereof

EP4087657A1 · Synthis Therapeutics, Inc. · Mar 18, 2026
Publication

Anti Cd40 Antibody Combination Treatment For Cancer

EP4143230A1 · Seagen Inc. · Mar 18, 2026
Publication

Lymphocytes Expressing Heterologous Targeting Constructs

EP4015525A2 · GammaDelta Therapeutics Limited · Mar 18, 2026
Publication

Modified J Chain

EP4011910A1 · IGM Biosciences, Inc. · Mar 18, 2026
Publication

Drug Related Transgene Expression

EP3943507A1 · Seattle Children's Hospital, dba Seattle Children's Research Institute · Mar 18, 2026
Publication

Peptides As Selective Gip Receptor Agonists

EP4110800A1 · SANOFI · Mar 18, 2026
Publication

Trop2 Targeting Antibody Drug Conjugate, And Preparation Method And Use Therefor

EP4265275A1 · Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. · Mar 18, 2026
Publication

Peptides And Uses Thereof

EP4132957A1 · Sintica Biotech Societa a Responsabilita Limitata Semplificata · Mar 18, 2026
Publication

Combination Treatment For Cancer Based Upon An Icos Antibody And A Pd L1 Antibody Tgf Beta Receptor Fusion Protein

EP4136105A1 · GlaxoSmithKline Intellectual Property Development Limited · Mar 18, 2026
Publication

Combination Treatment For Cancer Involving Anti Icos And Anti Pd1 Antibodies, Optionally Further Involving Anti Tim3 Antibodies

EP4136113A1 · GlaxoSmithKline Intellectual Property Development Limited · Mar 18, 2026
Publication

Anti Cd30 Chimeric Antigen Receptor And Its Use

EP3995512A1 · Abken, Hinrich · Mar 18, 2026
Publication

Antimicrobial Agents Against Salmonella Bacteria

EP3978605A1 · Lysando AG · Mar 18, 2026
Publication

Recombinant Fusion Proteins Targeting Cd47 And Pd L1, Preparation And Use Thereof

EP4151229A1 · ImmuneOnco Biopharmaceuticals (Shanghai) Inc. · Mar 18, 2026
Publication

Improved Cell Compositions And Methods For Cancer Therapy

EP4101461A1 · Hadasit Medical Research Services and Development Ltd. · Mar 18, 2026
Publication

Methods For Using Transcription Dependent Directed Evolution Of Aav Capsids

EP3917566A1 · Oregon Health & Science University · Mar 18, 2026
Publication

Small Molecule Degraders Of Fkbp12 Via Recruitment Of Von Hippel Lindau E3 Ubiquitin Ligase (Vhl) E3 Ubiquitin Ligase, And Uses In Dtag Systems

EP3908291A1 · Dana-Farber Cancer Institute, Inc. · Mar 18, 2026
Publication

Non Human Animals That Make Single Domain Binding Proteins

EP3895528A1 · Regeneron Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Aav Vectors For Retinal And Cns Gene Therapy

EP3913061A1 · Genzyme Corporation · Mar 18, 2026
Publication

Molecules With Altered Neonate Fc Receptor Binding Having Enhanced Therapeutic And Diagnostic Properties

EP3888690A2 · MedImmune, LLC · Mar 18, 2026
Publication

Methods For Protein Purification

EP3990639A1 · GlaxoSmithKline Biologicals S.A. · Mar 18, 2026
Publication

Car T Cells Targeting Bcma And Uses Thereof

EP3962949A1 · Celyad S.A. · Mar 18, 2026
Publication

Anti Integrin Antibodies And Uses Thereof

EP3953389A1 · Biogen MA Inc. · Mar 18, 2026
Publication

Novel Compounds And Therapeutic Uses Thereof

EP3947417A1 · Centauri Therapeutics Limited · Mar 18, 2026
Publication

Retroviral And Lentiviral Vectors

EP3904523A1 · Autolus Limited · Mar 18, 2026
Publication

Chimeric Proteins For Selective Lysis Of Bacteria

EP4051243A2 · Bactoclear Holdings Pte. Ltd. · Mar 18, 2026
Publication

Chimeric Antigen Receptors Against Human Cytomegalovirus

EP4041257A1 · The Regents of the University of California · Mar 18, 2026
Publication

Pentapeptide And Methods Of Use Thereof

EP4065171A1 · THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS · Mar 18, 2026
Publication

Antibodies Targeting, And Other Modulators Of, The Cd276 Antigen, And Uses Thereof

EP4061841A1 · Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts · Mar 18, 2026
Publication

Compositions And Methods For Immunotherapy

EP4058035A1 · Ludwig Institute for Cancer Research Ltd · Mar 18, 2026
Publication

Anti Tnf Alpha Humanized Monoclonal Antibody Tcx060 Having Low Immunogenicity And Low Adcc/Cdc Function, And Use Thereof

EP3967708A1 · Abmax Biopharmaceuticals · Mar 18, 2026
Publication

Bicyclic Peptide Ligand Drug Conjugates

EP4045089A1 · BicycleTX Limited · Mar 18, 2026
Publication

Flagellin Fusion Protein And Use Thereof

EP3960756A1 · Industry Foundation of Chonnam National University · Mar 18, 2026
Publication

Compositions And Methods Relating To Plant Messenger Packs

EP3959223A1 · Flagship Pioneering Innovations VI, LLC · Mar 18, 2026
Publication

Unraveling Receptor Metabolite Interactions In The Human Microbiome

EP3955938A1 · The Rockefeller University · Mar 18, 2026
Publication

Benzenesulfonamide Derivatives And Uses Thereof

EP4017843A1 · 2692372 Ontario, Inc. · Mar 18, 2026
Publication

Factor H Potentiating Antibodies And Uses Thereof

EP3999073A1 · Gemini Therapeutics Sub, Inc. · Mar 18, 2026
Publication

Modified Hemoglobin Molecules And Uses Thereof

EP3946431A1 · University of Pittsburgh - of the Commonwealth System of Higher Education · Mar 18, 2026
Publication

Anti Cd73, Anti Pd L1 Antibodies And Chemotherapy For Treating Tumors

EP3947447A1 · Medimmune, LLC · Mar 18, 2026
Publication

Liquid Composition Comprising Antibody Of Human Interleukin 4 Receptor Alpha

EP3939609A1 · Connect Biopharma HongKong Limited · Mar 18, 2026
Publication

Method For Selecting Subject Likely Benefiting From Pharmaceutical Composition For Treating Or Preventing Cancer

EP3932491A1 · International Institute of Cancer Immunology, Inc. · Mar 18, 2026
Publication

Antibody

EP3911683A1 · King's College London · Mar 18, 2026
Publication

Compositions And Methods For The Treatment Of Tauopathy

EP3963083A1 · Voyager Therapeutics, Inc. · Mar 18, 2026
Publication

A Paenibacillus Strain, Antifungal Compounds, And Methods For Their Use

EP3838914A1 · Bayer CropScience LLC · Mar 18, 2026
Publication

A Cell Based Method For Determining An Activity Of Botulinum Toxin

EP3825689A2 · Hugel Inc. · Mar 18, 2026
Publication

Peptides And Combinations Of Peptides For Use In Immunotherapy Against An Infection By Sars Cov 2 (Covid 19)

EP3892297A1 · Eberhard Karls Universität Tübingen Medizinische Fakultät · Mar 18, 2026
Publication

Tumor Necrosis Factor (Tnf) Superfamily Receptor Binding Molecules And Uses Thereof

EP3750918A1 · IGM Biosciences, Inc. · Mar 18, 2026
Publication

Psma Binding Antibody And Uses Thereof

EP3693396A2 · Deutsches Krebsforschungszentrum - Stiftung des öffentlichen Rechts / Universität Heidelberg · Mar 18, 2026
Publication

T Cell Receptors

EP3925972A1 · Adaptimmune Ltd · Mar 18, 2026
Publication

Multi Specific Binding Proteins That Bind Bcma, Nkg2 D And Cd16, And Methods Of Use

EP3833392A1 · Dragonfly Therapeutics, Inc. · Mar 18, 2026
Publication

Dual Agonist Fusion Proteins

EP3829622A1 · Duke University · Mar 18, 2026
Publication

Antitumor Antagonist Consisting Of A Mutated Tgfß1 Rii Extracellular Domain And An Immunoglobulin Scaffold

EP3990116A1 · Zelgen Holdings Limited · Mar 18, 2026
Publication

Fusion Protein With A Toxin And Scaffold Protein

EP3898658A1 · VIB VZW · Mar 18, 2026
Publication

Antibodies Directed Against Staphylococcus Aureus Leukotoxins

EP3864040A1 · Medimmune, LLC · Mar 18, 2026
Publication

High Affinity Monoclonal Antibodies (Mabs) Against Cell Surface Expressed Human Carbonic Anhydrase Ix (Hca Ix), And Uses Thereof

EP3784700A1 · National Research Council of Canada · Mar 18, 2026
Publication

Mycobacterial Antigen Compositions And Methods Of Use

EP3784275A2 · Children's National Medical Center · Mar 18, 2026
Publication

Anti Human Lag 3 Monoclonal Antibody And Use Thereof

EP3778632A1 · Jiangsu Huaiyu Pharmaceutical Co., Ltd. · Mar 18, 2026
Publication

Methods And Compositions For Blocking Interaction Between Non Glycosylated Pd 1 Polypeptides

EP3773916A1 · TrueBinding, Inc. · Mar 18, 2026
Publication

Recombinant Protein Targeting Pd L1 And Vegf

EP3891182A1 · ImmuneOnco Biopharmaceuticals (Shanghai) Inc. · Mar 18, 2026
Publication

Dpep 1 Binding Agents And Methods Of Use

EP3887390A1 · Arch Biopartners, Inc. · Mar 18, 2026
Publication

Anti Pd L1/Anti 4 1 Bb Bispecific Antibodies And Uses Thereof

EP3891187A1 · ABL Bio Inc. · Mar 18, 2026
Publication

Supar And Prediction And Treatment Of Acute Kidney Injury

EP3856244A1 · Reiser, Jochen · Mar 18, 2026
Publication

Suppressing Ige Mediated Allergy By Desensitization With Monovalent Anti Fc Epsilon Ri Alpha Monoclonal Antibody

EP3852804A1 · University of Cincinnati · Mar 18, 2026
Publication

Methods And Compositions Comprising Surfactant Protein D (Sp D)

EP3774875A1 · Airway Therapeutics, Inc. · Mar 18, 2026
Publication

Pichia Pastoris Mutant Strain For Expressing Exogenous Gene

EP3910062A1 · Wilmar (shanghai) Biotechnology Research & Development Center Co., Ltd. · Mar 18, 2026
Publication

Fusion Protein Constructs For Complement Associated Disease

EP3893916A2 · Akebia Therapeutics, Inc. · Mar 18, 2026
Publication

Completely Humanized Monoclonal Neutralizing Antibody For Tetanus Toxin And Application Thereof

EP3733699A1 · Zhuhai Trinomab Pharmaceutical Co., Ltd. · Mar 18, 2026
Publication

Method For Increasing Secretion Of Recombinant Protein

EP3680343A2 · Korea Advanced Institute of Science and Technology · Mar 18, 2026
Publication

Novel Method For Producing Antibody Drug Conjugate

EP3677568A1 · Daiichi Sankyo Company, Limited · Mar 18, 2026
Publication

Compounds Including A Mutant Kras Sequence And A Lipid And Uses Thereof

EP3758713A1 · Elicio Therapeutics, Inc. · Mar 18, 2026
Publication

Compositions And Methods For Treating Mitochondrial Neurogastrointestinal Encephalopathy

EP3755351A1 · Entrada Therapeutics, Inc. · Mar 18, 2026
Publication

Method Of Manufacturing A Therapeutic Protein

EP3693469A1 · Momenta Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Molecules For Use To Treat Or Prevent Cardiac Diseases

EP3835316A1 · Universiteit Gent · Mar 18, 2026
Publication

Ctla4 Binding Protein Peptide Linker Masks

EP3733696A1 · City of Hope · Mar 18, 2026
Publication

Diagnosis Of Blistering Autoimmune Diseases

EP3644060A1 · EUROIMMUN Medizinische Labordiagnostika AG · Mar 18, 2026
Publication

Synp61, A Primate Retinal Pigment Epithelium Cell Specific Promoter

EP3717509A1 · Friedrich Miescher Institute for Biomedical Research · Mar 18, 2026
Publication

Production Of Recombinant Vaccine Against Helminths In Pichia Pastoris

EP3572514A1 · Tendler, Miriam · Mar 18, 2026
Publication

Compositions And Methods Related To Engineered Fc Constructs

EP3565588A1 · Momenta Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Combination Of Lif Inhibitors And Pd 1 Axis Inhibitors For Use In Treating Cancer

EP3774895A1 · MedImmune Limited · Mar 18, 2026
Publication

Her2 Targeting Molecules Comprising De Immunized, Shiga Toxin A Subunit Scaffolds

EP3573652A1 · Molecular Templates, Inc. · Mar 18, 2026
Publication

Tick Vaccine

EP3781198A1 · Technische Universität Braunschweig · Mar 18, 2026
Publication

Engineered Cytolytic Immunecell

EP3775895A1 · Autolus Limited · Mar 18, 2026
Publication

Anti Cd25 For Tumour Specific Cell Depletion

EP3765510A1 · Tusk Therapeutics Ltd · Mar 18, 2026
Publication

Antibodies Recognizing Genetic Variants

EP3579873A1 · Roche Diagnostics GmbH · Mar 18, 2026
Publication

Bionconjugates Of Polysaccharides And Elastin Like Polypeptides And Uses Thereof

EP3628333A1 · Institut Polytechnique de Bordeaux · Mar 18, 2026
Publication

Processing Of Insect Larvae

EP3578052A1 · Bühler AG · Mar 18, 2026
Publication

Anti Cd40 Antibodies For Use In Prevention Of Graft Rejection

EP3774913A1 · Novartis AG · Mar 18, 2026
Publication

Uses And Methods For Il 2 Superagonists, Agonists, And Fusions Thereof

EP3641814A1 · Medicenna Therapeutics Inc. · Mar 18, 2026
Publication

Anti Cldn 5 Antibody, And Drug Containing Said Antibody

EP3623384A1 · Osaka University · Mar 18, 2026
Publication

Igf 1 R Monoclonal Antibodies And Uses Thereof

EP3638320A2 · Centre for Probe Development and Commercialization · Mar 18, 2026
Publication

Analytical And Therapeutic Methods And Compositions, And Uses Thereof

EP3615935A1 · Auckland Uniservices Limited · Mar 18, 2026
Publication

Anti Pd L1 Antibody And Use Thereof

EP3612565A1 · R-Pharm Overseas, Inc. · Mar 18, 2026
Publication

Binding Molecule Specific For Lrig 1 Protein And Use Thereof

EP3613772A2 · Good T Cells, Inc. · Mar 18, 2026
Publication

Mutant Alpha 1 Antitrypsin Compositions And Use Thereof

EP3606951A1 · B.G. Negev Technologies and Applications Ltd., at Ben-Gurion University · Mar 18, 2026
Publication

Compositions For The Treatment Of Disease

EP3448987A2 · Voyager Therapeutics, Inc. · Mar 18, 2026
Publication

Compositions For The Treatment Of Disease

EP3448875A1 · Voyager Therapeutics, Inc. · Mar 18, 2026
Publication

Method Of Treating Or Preventing Liver Conditions

EP3445450A1 · CSL Limited · Mar 18, 2026
Publication

Anti Human Vista Antibodies And Use Thereof

EP3442579A2 · Immunext, Inc. · Mar 18, 2026
Publication

High Affinity B7 H6 Antibodies And Antibody Fragments

EP3442576A1 · Trustees of Dartmouth College · Mar 18, 2026
Publication

Methods Of Treatment Using Chlorotoxin Conjugates

EP3442996A2 · Blaze Bioscience, Inc. · Mar 18, 2026
Publication

Plectin 1 Binding Antibodies And Uses Thereof

EP3439692A2 · ZIELBIO, INC. · Mar 18, 2026
Publication

Polypeptides Capable Of Forming Homo Oligomers With Modular Hydrogen Bond Network Mediated Specificity And Their Design

EP3436470A1 · University of Washington · Mar 18, 2026
Publication

Anti Il1 Rap Antibodies And Antibody Drug Conjugates

EP3638697A1 · Bluefin Biomedicine, Inc. · Mar 18, 2026
Publication

Three Dimensional Printed Organs, Devices, And Matrices

EP3635105A2 · Prellis Biologics, Inc. · Mar 18, 2026
Publication

C Terminal Cdnf And Manf Fragments, Pharmaceutical Compositions Comprising Same And Uses Thereof

EP3619227A1 · MyNeuroCure Oy · Mar 18, 2026
Publication

Anti Cgrp/Anti Il 23 Bispecific Antibodies And Uses Thereof

EP3618862A1 · Eli Lilly and Company · Mar 18, 2026
Publication

Improved T Cell Compositions And Methods

EP3612275A1 · Allogene Therapeutics, Inc. · Mar 18, 2026
Publication

Multispecific Molecules And Uses Thereof

EP3612563A1 · Marengo Therapeutics, Inc. · Mar 18, 2026
Publication

Amhrii Binding Compounds For Preventing Or Treating Lung Cancers

EP3609919A1 · Exelixis, Inc. · Mar 18, 2026
Publication

Amhrii Binding Compounds For Preventing Or Treating Cancers

EP3609918A1 · Exelixis, Inc. · Mar 18, 2026
Publication

Antibodies For The Treatment Of Erbb 2/Erbb 3 Positive Tumors

EP3600411A1 · Merus B.V. · Mar 18, 2026
Publication

A Fusion Peptide Comprising Glp 2 And Elastin Like Peptides

EP3412300A1 · Duke University · Mar 18, 2026
Publication

Anti Human Cd19 Antibodies With High Affinity

EP3356405A1 · F. Hoffmann-La Roche AG · Mar 18, 2026
Publication

Affinity Chromatography Purification With Low Conductivity Wash Buffer

EP3337818A1 · F. Hoffmann-La Roche AG · Mar 18, 2026
Publication

Heterodimeric Immunoglobulin Constructs And Preparation Methods Thereof

EP3504234A1 · Beijing Hanmi Pharmaceutical Co., Ltd. · Mar 18, 2026
Publication

Ebola Virus Antibodies And Binding Agents Derived Therefrom

EP3487521A2 · Emory University · Mar 18, 2026
Publication

Modification Of Transcriptional Repressor Binding Site In Nf Yc4 Promoter For Increased Protein Content And Resistance To Stress

EP3258774A1 · Iowa State University Research Foundation, Inc. · Mar 18, 2026
Publication

Cd73 Blockade

EP3259288A1 · Innate Pharma · Mar 18, 2026
Publication

A Combination Of Two Or More Anti C5 Antibodies And Methods Of Use

EP3247723A1 · Chugai Seiyaku Kabushiki Kaisha · Mar 18, 2026
Publication

Chimeric Antigen Receptors (Car) For Use In Therapy And Methods For Making The Same

EP3134437A1 · Board of Regents, The University of Texas System · Mar 18, 2026
Publication

Protein Aqueous Suspension

EP3064213A1 · Terumo Kabushiki Kaisha · Mar 18, 2026
Publication

Anti Zika Virus Antibodies And Methods Of Use

EP3484917A1 · Regeneron Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Polynucleotides Encoding Citrin For The Treatment Of Citrullinemia Type 2

EP3458081A1 · ModernaTX, Inc. · Mar 18, 2026
Publication

Bispecific Antibodies Against Her2 And Cd3

EP2699262A2 · Genmab A/S · Mar 18, 2026